Hubbry Logo
MicroorganismMicroorganismMain
Open search
Microorganism
Community hub
Microorganism
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Microorganism
Microorganism
Microorganism
View on Wikipedia
from Wikipedia

A cluster of Escherichia coli bacteria magnified 10,000 times
Part of a series on
Biology
Key components
Branches
Research
Applications

A microorganism, or microbe,[a] is an organism of microscopic size, which may exist in its single-celled form or as a colony of cells. The possible existence of unseen microbial life was suspected from antiquity, with an early attestation in Jain literature authored in 6th-century BC India. The scientific study of microorganisms began with their observation under the microscope in the 1670s by Anton van Leeuwenhoek. In the 1850s, Louis Pasteur found that microorganisms caused food spoilage, debunking the theory of spontaneous generation. In the 1880s, Robert Koch discovered that microorganisms caused the diseases tuberculosis, cholera, diphtheria, and anthrax.

Microorganisms are extremely diverse, representing most unicellular organisms in all three domains of life: two of the three domains, Archaea and Bacteria, only contain microorganisms. The third domain, Eukaryota, includes all multicellular organisms as well as many unicellular protists and protozoans that are microbes. Some protists are related to animals and some to green plants. Many multicellular organisms are also microscopic, namely micro-animals, some fungi, and some algae.

Microorganisms can have very different habitats, and live everywhere from the poles to the equator, in deserts, geysers, rocks, and the deep sea. Some are adapted to extremes such as very hot or very cold conditions, others to high pressure, and a few, such as Deinococcus radiodurans, to high radiation environments. Microorganisms also make up the microbiota found in and on all multicellular organisms. There is evidence that 3.45-billion-year-old Australian rocks once contained microorganisms, the earliest direct evidence of life on Earth.[1][2]

Microbes are important in human culture and health in many ways, serving to ferment foods and treat sewage, and to produce fuel, enzymes, and other bioactive compounds. Microbes are essential tools in biology as model organisms and have been put to use in biological warfare and bioterrorism. Microbes are a vital component of fertile soil. In the human body, microorganisms make up the human microbiota, including the essential gut flora. The pathogens responsible for many infectious diseases are microbes and, as such, are the target of hygiene measures.

Discovery

[edit]
See also: History of biology and Microbiology § History

Ancient precursors

[edit]
Antonie van Leeuwenhoek was the first to study microscopic organisms.
Lazzaro Spallanzani showed that boiling a broth stopped it from decaying.

The possible existence of microscopic organisms was discussed for many centuries before their discovery in the 17th century. By the 6th century BC, the Jains of present-day India postulated the existence of tiny organisms called nigodas.[3] These nigodas are said to be born in clusters; they live everywhere, including the bodies of plants, animals, and people; and their life lasts only for a fraction of a second.[4] According to Mahavira, the 24th preacher of Jainism, the humans destroy these nigodas on a massive scale, when they eat, breathe, sit, and move.[3] Many modern Jains assert that Mahavira's teachings presage the existence of microorganisms as discovered by science.[5]

The earliest known idea to indicate the possibility of diseases spreading by yet unseen organisms was that of the Roman scholar Marcus Terentius Varro in a 1st-century BC book entitled On Agriculture in which he called the unseen creatures animalia minuta, and warns against locating a homestead near a swamp:[6]

… and because there are bred certain minute creatures that cannot be seen by the eyes, which float in the air and enter the body through the mouth and nose and they cause serious diseases.[6]

In The Canon of Medicine (1020), Avicenna suggested that tuberculosis and other diseases might be contagious.[7][8]

Early modern

[edit]
Further information: Bacteria § History of bacteriology

In the 15th-century, Turkish scientist Akshamsaddin speculated about microbial life relating to disease in his work Maddat ul-Hayat (The Material of Life):

It is a mistake to assume that diseases appear in individuals one by one. Diseases are transmitted from person to person. This transmission takes place through small seeds that are invisible to the eye, but are still alive.[9][10]

In 1546, Girolamo Fracastoro proposed that epidemic diseases were caused by transferable seedlike entities that could transmit infection by direct or indirect contact, or even without contact over long distances.[11]

Antonie van Leeuwenhoek is considered to be one of the fathers of microbiology. He was the first in 1673 to discover and conduct scientific experiments with microorganisms, using simple single-lensed microscopes of his own design.[12][13][14][15] Robert Hooke, a contemporary of Leeuwenhoek, also used microscopy to observe microbial life in the form of the fruiting bodies of moulds. In his 1665 book Micrographia, he made drawings of studies, and he coined the term cell.[16]

19th century

[edit]
Louis Pasteur showed that Spallanzani's findings held even if air could enter through a filter that kept particles out.

Louis Pasteur (1822–1895) exposed boiled broths to the air, in vessels that contained a filter to prevent particles from passing through to the growth medium, and also in vessels without a filter, but with air allowed in via a curved tube so dust particles would settle and not come in contact with the broth. By boiling the broth beforehand, Pasteur ensured that no microorganisms survived within the broths at the beginning of his experiment. Nothing grew in the broths in the course of Pasteur's experiment. This meant that the living organisms that grew in such broths came from outside, as spores on dust, rather than spontaneously generated within the broth. Thus, Pasteur refuted the theory of spontaneous generation and supported the germ theory of disease.[17]

Robert Koch showed that microorganisms caused disease.

In 1876, Robert Koch (1843–1910) established that microorganisms can cause disease. He found that the blood of cattle that were infected with anthrax always had large numbers of Bacillus anthracis. Koch found that he could transmit anthrax from one animal to another by taking a small sample of blood from the infected animal and injecting it into a healthy one, and this caused the healthy animal to become sick. He also found that he could grow the bacteria in a nutrient broth, then inject it into a healthy animal, and cause illness. Based on these experiments, he devised criteria for establishing a causal link between a microorganism and a disease and these are now known as Koch's postulates.[18] Although these postulates cannot be applied in all cases, they do retain historical importance to the development of scientific thought and are still being used today.[19]

The discovery of microorganisms such as Euglena that did not fit into either the animal or plant kingdoms, since they were photosynthetic like plants, but motile like animals, led to the naming of a third kingdom in the 1860s. In 1860 John Hogg called this the Protoctista, and in 1866 Ernst Haeckel named it the Protista.[20][21][22]

The work of Pasteur and Koch did not accurately reflect the true diversity of the microbial world because of their exclusive focus on microorganisms having direct medical relevance. It was not until the work of Martinus Beijerinck and Sergei Winogradsky in the late 19th century that the true breadth of microbiology was revealed.[23] Beijerinck made two major contributions to microbiology: the discovery of viruses and the development of enrichment culture techniques.[24] While his work on the tobacco mosaic virus established the basic principles of virology, it was his development of enrichment culturing that had the most immediate impact on microbiology by allowing for the cultivation of a wide range of microbes with wildly different physiologies. Winogradsky was the first to develop the concept of chemolithotrophy and to thereby reveal the essential role played by microorganisms in geochemical processes.[25] He was responsible for the first isolation and description of both nitrifying and nitrogen-fixing bacteria.[23] French-Canadian microbiologist Félix d'Hérelle co-discovered bacteriophages and was one of the earliest applied microbiologists.[26]

Classification and structure

[edit]

Microorganisms can be found almost anywhere on Earth. Bacteria and archaea are almost always microscopic, while a number of eukaryotes are also microscopic, including most protists, some fungi, as well as some micro-animals and plants. Viruses are generally regarded as not living and therefore not considered to be microorganisms, although a subfield of microbiology is virology, the study of viruses.[27][28][29]

Evolution

[edit]
Further information: Timeline of the evolutionary history of life and Earliest known life forms

Single-celled microorganisms were the first forms of life to develop on Earth, approximately 3.5 billion years ago.[30][31][32] Further evolution was slow,[33] and for about 3 billion years in the Precambrian eon, (much of the history of life on Earth), all organisms were microorganisms.[34][35] Bacteria, algae and fungi have been identified in amber that is 220 million years old, which shows that the morphology of microorganisms has changed little since at least the Triassic period.[36] The newly discovered biological role played by nickel, however – especially that brought about by volcanic eruptions from the Siberian Traps – may have accelerated the evolution of methanogens towards the end of the Permian–Triassic extinction event.[37]

Microorganisms tend to have a relatively fast rate of evolution. Most microorganisms can reproduce rapidly, and bacteria are also able to freely exchange genes through conjugation, transformation and transduction, even between widely divergent species.[38] This horizontal gene transfer, coupled with a high mutation rate and other means of transformation, allows microorganisms to swiftly evolve (via natural selection) to survive in new environments and respond to environmental stresses. This rapid evolution is important in medicine, as it has led to the development of multidrug resistant pathogenic bacteria, superbugs, that are resistant to antibiotics.[39]

A possible transitional form of microorganism between a prokaryote and a eukaryote was discovered in 2012 by Japanese scientists. Parakaryon myojinensis is a unique microorganism larger than a typical prokaryote, but with nuclear material enclosed in a membrane as in a eukaryote, and the presence of endosymbionts. This is seen to be the first plausible evolutionary form of microorganism, showing a stage of development from the prokaryote to the eukaryote.[40][41]

Archaea

[edit]
Main article: Archaea
Further information: Prokaryote

Archaea are prokaryotic unicellular organisms, and form the first domain of life in Carl Woese's three-domain system. A prokaryote is defined as having no cell nucleus or other membrane bound-organelle. Archaea share this defining feature with the bacteria with which they were once grouped. In 1990 the microbiologist Woese proposed the three-domain system that divided living things into bacteria, archaea and eukaryotes,[42] and thereby split the prokaryote domain.

Archaea differ from bacteria in both their genetics and biochemistry. For example, while bacterial cell membranes are made from phosphoglycerides with ester bonds, Achaean membranes are made of ether lipids.[43] Archaea were originally described as extremophiles living in extreme environments, such as hot springs, but have since been found in all types of habitats.[44] Only now are scientists beginning to realize how common archaea are in the environment, with Thermoproteota (formerly Crenarchaeota) being the most common form of life in the ocean, dominating ecosystems below 150 metres (490 ft) in depth.[45][46] These organisms are also common in soil and play a vital role in ammonia oxidation.[47]

The combined domains of archaea and bacteria make up the most diverse and abundant group of organisms on Earth and inhabit practically all environments where the temperature is below +140 °C (284 °F). They are found in water, soil, air, as the microbiome of an organism, hot springs and even deep beneath the Earth's crust in rocks.[48] The number of prokaryotes is estimated to be around five nonillion, or 5 × 1030, accounting for at least half the biomass on Earth.[49]

The biodiversity of the prokaryotes is unknown, but may be very large. A May 2016 estimate, based on laws of scaling from known numbers of species against the size of organism, gives an estimate of perhaps 1 trillion species on the planet, of which most would be microorganisms. Currently, only one-thousandth of one percent of that total have been described.[50] Archael cells of some species aggregate and transfer DNA from one cell to another through direct contact, particularly under stressful environmental conditions that cause DNA damage.[51][52]

Bacteria

[edit]
Main article: Bacteria
Staphylococcus aureus bacteria magnified about 10,000×

Like archaea, bacteria are prokaryotic – unicellular, and having no cell nucleus or other membrane-bound organelle. Bacteria are microscopic, with a few extremely rare exceptions, such as Thiomargarita namibiensis.[53] Bacteria function and reproduce as individual cells, but they can often aggregate in multicellular colonies.[54] Some species such as myxobacteria can aggregate into complex swarming structures, operating as multicellular groups as part of their life cycle,[55] or form clusters in bacterial colonies such as E. coli.

Their genome is usually a circular bacterial chromosome – a single loop of DNA, although they can also harbor small pieces of DNA called plasmids. These plasmids can be transferred between cells through bacterial conjugation. Bacteria have an enclosing cell wall, which provides strength and rigidity to their cells. They reproduce by binary fission or sometimes by budding, but do not undergo meiotic sexual reproduction. However, many bacterial species can transfer DNA between individual cells by a horizontal gene transfer process referred to as natural transformation.[56] Some species form extraordinarily resilient spores, but for bacteria this is a mechanism for survival, not reproduction. Under optimal conditions bacteria can grow extremely rapidly and their numbers can double as quickly as every 20 minutes.[57]

Eukaryotes

[edit]
Main article: Eukaryote

Most living things that are visible to the naked eye in their adult form are eukaryotes, including humans. However, many eukaryotes are also microorganisms. Unlike bacteria and archaea, eukaryotes contain organelles such as the cell nucleus, the Golgi apparatus and mitochondria in their cells. The nucleus is an organelle that houses the DNA that makes up a cell's genome. DNA (Deoxyribonucleic acid) itself is arranged in complex chromosomes.[58] Mitochondria are organelles vital in metabolism as they are the site of the citric acid cycle and oxidative phosphorylation. They evolved from symbiotic bacteria and retain a remnant genome.[59] Like bacteria, plant cells have cell walls, and contain organelles such as chloroplasts in addition to the organelles in other eukaryotes. Chloroplasts produce energy from light by photosynthesis, and were also originally symbiotic bacteria.[59]

Unicellular eukaryotes consist of a single cell throughout their life cycle. This qualification is significant since most multicellular eukaryotes consist of a single cell called a zygote only at the beginning of their life cycles. Microbial eukaryotes can be either haploid or diploid, and some organisms have multiple cell nuclei.

Unicellular eukaryotes usually reproduce asexually by mitosis under favorable conditions. However, under stressful conditions such as nutrient limitations and other conditions associated with DNA damage, they tend to reproduce sexually by meiosis and syngamy.[60]

Protists

[edit]
Main article: Protista
Euglena mutabilis, a photosynthetic flagellate

Of eukaryotic groups, the protists are most commonly unicellular and microscopic. This is a highly diverse group of organisms that are not easy to classify.[61][62] Several algae species are multicellular protists, and slime molds have unique life cycles that involve switching between unicellular, colonial, and multicellular forms.[63] The number of species of protists is unknown since only a small proportion has been identified. Protist diversity is high in oceans, deep sea-vents, river sediment and an acidic river, suggesting that many eukaryotic microbial communities may yet be discovered.[64][65]

Fungi

[edit]
Main article: Fungus

The fungi have several unicellular species, such as baker's yeast (Saccharomyces cerevisiae) and fission yeast (Schizosaccharomyces pombe). Some fungi, such as the pathogenic yeast Candida albicans, can undergo phenotypic switching and grow as single cells in some environments, and filamentous hyphae in others.[66]

Plants

[edit]
Main article: Plant

The green algae are a large group of photosynthetic eukaryotes that include many microscopic organisms. Although some green algae are classified as protists, others such as charophyta are classified with embryophyte plants, which are the most familiar group of land plants. Algae can grow as single cells, or in long chains of cells. The green algae include unicellular and colonial flagellates, usually but not always with two flagella per cell, as well as various colonial, coccoid, and filamentous forms. In the Charales, which are the algae most closely related to higher plants, cells differentiate into several distinct tissues within the organism. There are about 6000 species of green algae.[67]

Ecology

[edit]
Main article: Microbial ecology

Microorganisms are found in almost every habitat present in nature, including hostile environments such as the North and South poles, deserts, geysers, and rocks. They also include all the marine microorganisms of the oceans and deep sea. Some types of microorganisms have adapted to extreme environments and sustained colonies; these organisms are known as extremophiles. Extremophiles have been isolated from rocks as much as 7 kilometres below the Earth's surface,[68] and it has been suggested that the amount of organisms living below the Earth's surface is comparable with the amount of life on or above the surface.[48] Extremophiles have been known to survive for a prolonged time in a vacuum, and can be highly resistant to radiation, which may even allow them to survive in space.[69] Many types of microorganisms have intimate symbiotic relationships with other larger organisms; some of which are mutually beneficial (mutualism), while others can be damaging to the host organism (parasitism). If microorganisms can cause disease in a host they are known as pathogens. Microorganisms play critical roles in Earth's biogeochemical cycles as they are responsible for decomposition and nitrogen fixation.[70]

Bacteria use regulatory networks that allow them to adapt to almost every environmental niche on earth.[71][72] A network of interactions among diverse types of molecules including DNA, RNA, proteins and metabolites, is utilised by the bacteria to achieve regulation of gene expression. In bacteria, the principal function of regulatory networks is to control the response to environmental changes, for example nutritional status and environmental stress.[73] A complex organization of networks permits the microorganism to coordinate and integrate multiple environmental signals.[71]

Extremophiles

[edit]
Main article: Extremophile
Further information: List of microorganisms tested in outer space
A tetrad of Deinococcus radiodurans, a radioresistant extremophile bacterium

Extremophiles are microorganisms that have adapted so that they can survive and even thrive in extreme environments that are normally fatal to most life-forms. Thermophiles and hyperthermophiles thrive in high temperatures. Psychrophiles thrive in extremely low temperatures. – Temperatures as high as 130 °C (266 °F),[74] as low as −17 °C (1 °F)[75] Halophiles such as Halobacterium salinarum (an archaean) thrive in high salt conditions, up to saturation.[76] Alkaliphiles thrive in an alkaline pH of about 8.5–11.[77] Acidophiles can thrive in a pH of 2.0 or less.[78] Piezophiles thrive at very high pressures: up to 1,000–2,000 atm, down to 0 atm as in a vacuum of space.[b] A few extremophiles such as Deinococcus radiodurans are radioresistant,[80] resisting radiation exposure of up to 5k Gy. Extremophiles are significant in different ways. They extend terrestrial life into much of the Earth's hydrosphere, crust and atmosphere, their specific evolutionary adaptation mechanisms to their extreme environment can be exploited in biotechnology, and their very existence under such extreme conditions increases the potential for extraterrestrial life.[81]

Plants and soil

[edit]
Main article: Soil biology

The nitrogen cycle in soils depends on the fixation of atmospheric nitrogen. This is achieved by a number of diazotrophs. One way this can occur is in the root nodules of legumes that contain symbiotic bacteria of the genera Rhizobium, Mesorhizobium, Sinorhizobium, Bradyrhizobium, and Azorhizobium.[82]

The roots of plants create a narrow region known as the rhizosphere that supports many microorganisms known as the root microbiome.[83]

These microorganisms in the root microbiome are able to interact with each other and surrounding plants through signals and cues. For example, mycorrhizal fungi are able to communicate with the root systems of many plants through chemical signals between both the plant and fungi. This results in a mutualistic symbiosis between the two. However, these signals can be eavesdropped by other microorganisms, such as the soil bacteria, Myxococcus xanthus, which preys on other bacteria. Eavesdropping, or the interception of signals from unintended receivers, such as plants and microorganisms, can lead to large-scale, evolutionary consequences. For example, signaler-receiver pairs, like plant-microorganism pairs, may lose the ability to communicate with neighboring populations because of variability in eavesdroppers. In adapting to avoid local eavesdroppers, signal divergence could occur and thus, lead to the isolation of plants and microorganisms from the inability to communicate with other populations.[84]

Symbiosis

[edit]
The photosynthetic cyanobacterium Hyella caespitosa (round shapes) with fungal hyphae (translucent threads) in the lichen Pyrenocollema halodytes

A lichen is a symbiosis of a macroscopic fungus with photosynthetic microbial algae or cyanobacteria.[85][86]

Applications

[edit]
Main article: Human interactions with microbes

Microorganisms are useful in producing foods, treating waste water, creating biofuels and a wide range of chemicals and enzymes. They are invaluable in research as model organisms. They have been weaponised and sometimes used in warfare and bioterrorism. They are vital to agriculture through their roles in maintaining soil fertility and in decomposing organic matter. They also have applications in aquaculture, such as in biofloc technology.

Food production

[edit]
Main articles: Fermentation in food processing and Food microbiology

Microorganisms are used in a fermentation process to make yoghurt, cheese, curd, kefir, ayran, xynogala, and other types of food. Fermentation cultures provide flavour and aroma, and inhibit undesirable organisms.[87] They are used to leaven bread, and to convert sugars to alcohol in wine and beer. Microorganisms are used in brewing, wine making, baking, pickling and other food-making processes.[88]

Example industrial uses of microorganisms
Product Contribution of microorganisms
Cheese Growth of microorganisms contributes to ripening and flavor. The flavor and appearance of a particular cheese is due in large part to the microorganisms associated with it. Lactobacillus Bulgaricus is one of the microbes used in production of dairy products
Alcoholic beverages Yeast is used to convert sugar, grape juice, or malt-treated grain into alcohol. Other microorganisms may also be used; a mold converts starch into sugar to make the Japanese rice wine, sake. Acetobacter Aceti a kind of bacterium is used in production of alcoholic beverages
Vinegar Certain bacteria are used to convert alcohol into acetic acid, which gives vinegar its acid taste. Acetobacter Aceti is used on production of vinegar, which gives vinegar odor of alcohol and alcoholic taste
Citric acid Certain fungi are used to make citric acid, a common ingredient of soft drinks and other foods.
Vitamins Microorganisms are used to make vitamins, including C, B2 , B12.
Antibiotics With only a few exceptions, microorganisms are used to make antibiotics. Penicillin, Amoxicillin, Tetracycline, and Erythromycin

Water treatment

[edit]
Further information: Drinking water § Water quality
Wastewater treatment treatment plants rely largely on microorganisms to oxidise organic matter.

These depend for their ability to clean up water contaminated with organic material on microorganisms that can respire dissolved substances. Respiration may be aerobic, with a well-oxygenated filter bed such as a slow sand filter.[89] Anaerobic digestion by methanogens generate useful methane gas as a by-product.[90]

Energy

[edit]

Microorganisms are used in fermentation to produce ethanol,[91] and in biogas reactors to produce methane.[92] Scientists are researching the use of algae to produce liquid fuels,[93] and bacteria to convert various forms of agricultural and urban waste into usable fuels.[94]

Chemicals, enzymes

[edit]
Further information: Synthesis of nanoparticles by fungi

Microorganisms are used to produce many commercial and industrial chemicals, enzymes and other bioactive molecules. Organic acids produced on a large industrial scale by microbial fermentation include acetic acid produced by acetic acid bacteria such as Acetobacter aceti, butyric acid made by the bacterium Clostridium butyricum, lactic acid made by Lactobacillus and other lactic acid bacteria,[95] and citric acid produced by the mould fungus Aspergillus niger.[95]

Microorganisms are used to prepare bioactive molecules such as Streptokinase from the bacterium Streptococcus,[96] Cyclosporin A from the ascomycete fungus Tolypocladium inflatum,[97] and statins produced by the yeast Monascus purpureus.[98]

Science

[edit]
See also: Genetically modified bacteria
A laboratory fermentation vessel

Microorganisms are essential tools in biotechnology, biochemistry, genetics, and molecular biology. The yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe are important model organisms in science, since they are simple eukaryotes that can be grown rapidly in large numbers and are easily manipulated.[99] They are particularly valuable in genetics, genomics and proteomics.[100][101] Microorganisms can be harnessed for uses such as creating steroids and treating skin diseases. Scientists are also considering using microorganisms for living fuel cells,[102] and as a solution for pollution.[103]

Warfare

[edit]
Main articles: Biological warfare and Bioterrorism

In the Middle Ages, as an early example of biological warfare, diseased corpses were thrown into castles during sieges using catapults or other siege engines. Individuals near the corpses were exposed to the pathogen and were likely to spread that pathogen to others.[104]

In modern times, bioterrorism has included the 1984 Rajneeshee bioterror attack[105] and the 1993 release of anthrax by Aum Shinrikyo in Tokyo.[106]

Soil

[edit]
Main article: Soil microbiology

Microbes can make nutrients and minerals in the soil available to plants, produce hormones that spur growth, stimulate the plant immune system and trigger or dampen stress responses. In general a more diverse set of soil microbes results in fewer plant diseases and higher yield.[107]

Human health

[edit]

Human gut flora

[edit]
Further information: Human microbiota and Human Microbiome Project

Microorganisms can form an endosymbiotic relationship with other, larger organisms. For example, microbial symbiosis plays a crucial role in the immune system. The microorganisms that make up the gut flora in the gastrointestinal tract contribute to gut immunity, synthesize vitamins such as folic acid and biotin, and ferment complex indigestible carbohydrates.[108] Some microorganisms that are seen to be beneficial to health are termed probiotics and are available as dietary supplements, or food additives.[109]

Disease

[edit]
Main articles: Pathogen and Germ theory of disease
Further information: Medical microbiology and Parasite
The eukaryotic parasite Plasmodium falciparum (spiky blue shapes), a causative agent of malaria, in human blood

Microorganisms are the causative agents (pathogens) in many infectious diseases. The organisms involved include pathogenic bacteria, causing diseases such as plague, tuberculosis and anthrax; protozoan parasites, causing diseases such as malaria, sleeping sickness, dysentery and toxoplasmosis; and also fungi causing diseases such as ringworm, candidiasis or histoplasmosis. However, other diseases such as influenza, yellow fever or AIDS are caused by pathogenic viruses, which are not usually classified as living organisms and are not, therefore, microorganisms by the strict definition. No clear examples of archaean pathogens are known,[110] although a relationship has been proposed between the presence of some archaean methanogens and human periodontal disease.[111] Numerous microbial pathogens are capable of sexual processes that appear to facilitate their survival in their infected host.[112]

Hygiene

[edit]
Main articles: Hygiene and Food microbiology

Hygiene is a set of practices to avoid infection or food spoilage by eliminating microorganisms from the surroundings. As microorganisms, in particular bacteria, are found virtually everywhere, harmful microorganisms may be reduced to acceptable levels rather than actually eliminated. In food preparation, microorganisms are reduced by preservation methods such as cooking, cleanliness of utensils, short storage periods, or by low temperatures. If complete sterility is needed, as with surgical equipment, an autoclave is used to kill microorganisms with heat and pressure.[113][114]

In fiction

[edit]

See also

[edit]

Notes

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Microorganism

View on Grokipedia
from Grokipedia

A microorganism, or microbe, is a microscopic organism too small to be seen with the naked eye, requiring magnification for observation, and typically includes unicellular or simple multicellular entities such as bacteria, archaea, fungi, protozoa, and algae, while viruses—acellular infectious agents—are frequently grouped with them despite lacking independent metabolism or reproduction.
Microorganisms exhibit immense diversity, spanning all three domains of life—Bacteria, Archaea, and Eukarya—and dominate Earth's biomass, inhabiting extreme environments from hydrothermal vents to acidic soils and human microbiomes.
They drive essential ecological processes, including nutrient cycling through nitrogen fixation, decomposition of organic matter, and symbiotic relationships that enable host survival, without which complex life forms could not persist.
Certain pathogenic microbes, however, cause infectious diseases by invading hosts and disrupting physiological functions, contributing to significant morbidity and mortality across species.
First observed in the 1670s by Antonie van Leeuwenhoek using self-crafted microscopes, microorganisms revolutionized biology, revealing an invisible world foundational to understanding life, disease, and biotechnology.

Historical Development

Pre-Scientific Observations and Early Theories

In and Roman texts, observations of processes such as , , and transmission prompted speculations about invisible agents at work, though these were often framed within theories of rather than discrete living entities. For instance, Roman author , in his 36 BCE treatise Rerum Rusticarum, described minute, unseen "animalcules" carried by air that could invade the body via mouth or nostrils to cause , marking an early empirical inference of subvisible causal factors in decay and illness. Similarly, (384–322 BCE) posited in that certain organisms, including insects and small aquatic life, arose spontaneously from decaying , such as mud or flesh, attributing this to inherent vital forces in non-living substrates rather than unobserved precursors. These ideas persisted due to the absence of tools to verify causation, conflating correlation in decay with direct origination from matter itself. Medieval alchemical and iatrochemical traditions extended Aristotelian , viewing generation from decay as a transformative principle akin to chemical transmutation, though empirical scrutiny remained limited. Practitioners like those influenced by Arabic translations of integrated spontaneous emergence into explanations of and rot, seeing it as evidence of latent "seeds" activated by environmental conditions without external biotic input. A notable example of flawed causal attribution came from Flemish chemist Jan Baptista van Helmont (1579–1644), whose posthumously published Ortus Medicinae (1648) included a claiming mice could arise spontaneously from grains and soiled left in a for 21 days, interpreting the process as a chemical "" yielding from inorganic and organic refuse. This reflected a reliance on observational over controlled isolation of variables, overlooking biotic intermediaries like eggs or contaminants. By the mid-17th century, experimental challenges began eroding unqualified for macroscopic organisms, emphasizing the need for causal verification through exclusion of potential agents. Italian physician , in his 1668 work Esperienze Intorno alla Generazione degli Insetti, demonstrated via sealed and gauze-covered meat jars that maggots appeared only where flies could access and lay eggs, not from the meat alone, thus disproving for visible invertebrates while leaving room for it in "simpler" forms. Concurrently, English scientist Robert Hooke's (1665) revealed compartmental structures he termed "cells" in cork slices viewed under an early compound , providing the first empirical glimpse of subvisible organization in dead plant material, though not yet linked to living microbes or dynamic processes. These efforts highlighted a shift toward first-principles testing—isolating conditions to trace origins—foreshadowing rejections of abiogenesis through reproducible exclusion of hidden causes.

Microscope Era and Initial Discoveries

The development of practical microscopes in the 17th century enabled the first direct visualizations of microorganisms, shifting observations from macroscopic inferences to empirical sightings of cellular entities. Antonie van Leeuwenhoek, a Dutch draper and self-taught microscopist, crafted single-lens microscopes magnifying up to 270 times, far surpassing compound lenses of the era plagued by spherical aberration. In 1674, examining lake water from Delft, he observed tiny unicellular organisms he termed "animalcules," describing their shapes, sizes, and movements in detailed letters to the Royal Society. These included forms resembling bacteria, such as rod-shaped and spherical entities in samples from pepper infusions and mouth scrapings, where he noted vast multitudes—estimating millions per droplet—swarming with vigorous motility, underscoring their ubiquity in everyday environments like water and human tissues. Leeuwenhoek's findings challenged prevailing notions of spontaneous generation by revealing a teeming invisible world requiring magnification for detection, yet debates persisted into the 18th century over microbial origins. In 1745, English priest John Needham boiled nutrient broths infused with plant or animal matter for short durations, then sealed them loosely; microbial growth ensued, which he interpreted as evidence of abiogenesis from non-living infusions. Italian biologist Lazzaro Spallanzani refuted this in 1765–1768 by prolonging boiling times to one hour and hermetically sealing flasks, preventing growth and attributing Needham's results to incomplete sterilization allowing aerial contaminants—microbes ubiquitous in air—to enter. Spallanzani's sealed-flask experiments causally linked the absence of microbes to exclusion of external sources, highlighting observational limits of early microscopes in discerning contamination mechanisms without refined techniques. Microscopy advanced in the 19th century with achromatic lenses, invented by figures like and Giovanni Battista Amici, which corrected chromatic and spherical aberrations for sharper images at higher magnifications. These refinements, emerging around 1820–1830, allowed clearer delineation of microbial motility, such as flagellar whipping in , and morphological diversity in unstained preparations, revealing dynamic behaviors previously obscured by optical distortions. Early quantitative assessments, building on Leeuwenhoek's counts, estimated microbial densities in the millions per milliliter of natural waters, affirming their pervasive presence across ecosystems and prompting causal inquiries into their roles beyond mere visibility.

Germ Theory Establishment

The establishment of germ theory in the 19th century relied on empirical experiments demonstrating that microorganisms, rather than or miasmas, caused , decay, and infectious diseases. 's swan-neck flask experiments, conducted between 1859 and 1864, provided decisive evidence against by showing that boiled nutrient broth remained sterile when exposed to air through a curved neck that trapped dust and microbes, but spoiled rapidly upon neck breakage or tilting, allowing contamination. These results, presented to the in 1861, indicated that microbes originated from airborne parental forms, not spontaneous emergence under observable conditions, thus supporting contagion via living agents. Robert Koch advanced causal specificity by developing postulates to link particular microbes to particular diseases, first through his 1876 investigation of . Koch isolated Bacillus anthracis from infected animals, grew it in pure culture, demonstrated spore formation enabling environmental persistence, and reproduced fatal upon inoculation into healthy subjects while reisolating the identical bacterium. In 1882, applying refined techniques, Koch identified the rod-shaped as the tubercle bacillus, culturing it from lung lesions, inducing in guinea pigs, and confirming its presence in all examined cases, thereby fulfilling his criteria for microbial etiology. These postulates emphasized isolation, reproduction of , and re-isolation as necessary for establishing , shifting toward verifiable pathogen-specific mechanisms. Joseph Lister integrated these insights into clinical practice with antiseptic surgery introduced in 1867. Inspired by Pasteur's findings on microbial contamination, Lister applied carbolic acid (phenol) to wounds, dressings, and surgical instruments, reducing airborne and contact transmission of sepsis-causing microbes. In his series, mortality from compound fractures—previously around 45% due to —fell to approximately 15%, representing a roughly two-thirds reduction attributable to antisepsis, as evidenced by lower pus formation and incidence. Early germ theory encountered critiques for insufficiently accounting for host and environmental variables in outcomes, as pathogen presence alone did not invariably produce illness. Observers noted variability where identical exposures yielded in some hosts but not others, suggesting innate resistance, nutrition, or prior sensitization modulated causality beyond microbial invasion. Such limitations highlighted that while microbes were necessary agents, sufficient causation often required compromised host defenses, tempering monocausal interpretations.

Post-Koch Advances and Molecular Era

Following Robert Koch's establishment of pure culture techniques in the late 19th century, microbiology shifted toward therapeutic applications with the discovery of antimicrobial agents. In 1928, Alexander Fleming observed that a mold contaminant, Penicillium notatum, inhibited the growth of Staphylococcus bacteria on a culture plate, identifying the active compound as penicillin. This serendipitous finding laid the groundwork for antibiotics, though initial extraction proved challenging. In the early 1940s, Howard Florey and Ernst Chain at Oxford University developed methods to purify and concentrate penicillin, demonstrating its efficacy in treating bacterial infections in mice and humans, which dramatically reduced mortality from sepsis and other infections during World War II. Their work enabled mass production, marking a paradigm shift from microbial identification to targeted eradication, with penicillin's selective toxicity sparing host cells while killing bacteria. The mid-20th century saw further advances in biochemical characterization, but the 1970s ushered in the molecular era through recombinant DNA technology. In 1973, Stanley Cohen and Herbert Boyer demonstrated the construction of recombinant plasmids by inserting foreign DNA—such as from the African clawed frog—into Escherichia coli via restriction enzymes and ligation, enabling bacterial cloning and expression of non-native genes. This breakthrough overcame limitations of pure culturing by allowing genetic manipulation of microorganisms, facilitating the production of human proteins like insulin in bacteria by the late 1970s and expanding understanding of microbial genetics beyond phenotypic observation. By the 1980s, (PCR), conceived by in 1983 and refined at , revolutionized microbial detection by exponentially amplifying specific DNA segments from minute samples, bypassing the need for viable cultures. PCR enabled precise identification of unculturable or fastidious microbes through , supporting causal links in infections via genetic evidence rather than solely morphological or growth-based criteria. Concurrently, epidemiological data challenged unbridled sanitation drives; David Strachan's 1989 hygiene hypothesis, based on British cohort studies, showed that smaller family sizes—correlating with reduced early microbial exposure—inversely associated with hay fever prevalence, suggesting modern hygiene reduces immune priming against allergens and . This data-driven perspective highlighted trade-offs in microbial deprivation, emphasizing balanced exposure for immune calibration over absolute sterility.

Contemporary Insights and Omics Revolutions

The advent of high-throughput sequencing technologies since the early 2000s has revolutionized through approaches, enabling comprehensive genomic, transcriptomic, and analyses that reveal the vast uncultured microbial diversity previously inaccessible via traditional cultivation methods. , in particular, has uncovered millions of novel microbial genomes from environmental samples, highlighting functional genes involved in biogeochemical cycles and host interactions that challenge prior underestimations of microbial roles in ecosystems. For instance, the Human Microbiome Project, initiated in 2007 by the , sequenced microbial communities across healthy human body sites, estimating approximately 10^13 to 10^14 microbial cells, predominantly , which collectively encode over 3 million unique genes—far exceeding the human genome's ~20,000. This work debunked the long-held notion of a 10:1 -to-human cell , with revised calculations indicating roughly 38 trillion bacterial cells against 30 trillion human cells in a typical adult, emphasizing a near 1:1 parity and underscoring microbes' integral contributions to host . Recent metagenomic surveys from 2023 to 2025 have further illuminated uncultured microbial lineages, such as those in marine environments, where novel probes track real-time degradation by microbes, revealing mechanisms of carbon that influence global sequestration and climate dynamics. These advances, including fluorescent sugar analogs, demonstrate how uncultured bacterioplankton break down complex from algal blooms, with implications for modeling oceanic productivity. Similarly, and plant-associated metagenomes have identified new phytopathogenic strains and resistance s, expanding known threats to amid climate shifts. The virosphere, probed via , emerges as extraordinarily vast, with estimates of 10^31 virus particles globally—tenfold exceeding bacterial counts—and encompassing diverse and DNA viruses that drive microbial and transfer. Such discoveries highlight the limitations of culture-based , as over 80% of detected microbial operational taxonomic units remain unclassified at the species level. Omics-driven causal inferences have linked microbial to disease states, exemplified by fecal microbiota transplantation (FMT) trials establishing restoration as a therapeutic mechanism. In recurrent Clostridioides difficile infections, a 2013 randomized reported 81% resolution after FMT via duodenal infusion, rising to over 90% in subsequent ambulatory protocols, contrasting with ~30% antibiotic recurrence rates and affirming as a causal driver reversible by donor engraftment. These outcomes, supported by metagenomic tracking of increased donor-like diversity post-FMT, extend to exploratory links with non-infectious conditions like , though efficacy varies and requires rigorous controls to distinguish correlation from causation. Overall, revolutions prioritize empirical genomic evidence over speculative models, revealing microbial communities as dynamic networks with quantifiable impacts on and .

Fundamental Characteristics

Definition and Scope

Microorganisms, or microbes, are organisms characterized by their , typically measuring less than 0.1 mm in any dimension, rendering them invisible to the and necessitating microscopic examination for observation. This category primarily includes unicellular prokaryotes such as and , as well as unicellular or simple multicellular eukaryotes like , yeasts, and unicellular , provided they maintain an overall microscopic size. Multicellular aggregates, such as certain slime molds in their plasmodial stage, may fall within scope if predominantly microscopic, but macroscopic multicellular forms like filamentous fungi or vascular are excluded. Classification as a microorganism requires fulfillment of core processes, including possession of cellular structure, capacity for independent , growth through nutrient assimilation, asexual or , and responsiveness to environmental stimuli. These criteria delineate living microbes from acellular replicators: viruses, which consist of nucleic acids encased in protein coats and depend entirely on host cells for replication without autonomous , are regarded as non-cellular entities on the boundary of . Prions, misfolded proteins capable of inducing conformational changes in homologous proteins but lacking nucleic acids or metabolic activity, are categorically excluded as non-living infectious agents. The scope of microorganisms underscores their ubiquity and dominance in Earth's , with prokaryotic cells alone estimated at around 10^{30} individuals, far exceeding the count of eukaryotic cells or larger organisms. They comprise a substantial of global , particularly in aquatic systems where prokaryotes represent over 90% of marine living , driving biogeochemical cycles through their metabolic activities. This vast reflects their adaptive success in diverse habitats, from soils and sediments to extreme environments, though viroids and other subviral agents remain outside microbial boundaries due to absence of protein components or independent replication.

Size, Morphology, and Visibility

Microorganisms vary markedly in size, with viruses typically ranging from 20 to 300 nanometers in diameter, rendering them submicroscopic and below the resolution of light microscopes. Bacterial cells generally measure 0.5 to 5 micrometers in length or diameter, exemplified by at approximately 1 to 2 micrometers long and 0.5 micrometers in diameter. Eukaryotic microorganisms, such as , span 1 to 50 micrometers, while fungal hyphae exhibit diameters of 1 to 30 micrometers. These dimensions facilitate intimate interactions with environments, such as nutrient diffusion in smaller forms and structural support in larger ones. Morphological diversity includes spherical cocci (0.5 to 2 micrometers in diameter), rod-shaped (1 to 10 micrometers long), and helical spirilla for bacteria, each conferring advantages like surface area optimization or . Fungal hyphae form elongated, branching filaments that enable substrate penetration and resource foraging. Such forms arise from cell wall rigidity and cytoskeletal dynamics, influencing adhesion and environmental persistence. Visibility depends on microscopy limits; light microscopes resolve down to approximately 200 nanometers, sufficient for and larger eukaryotes but inadequate for most viruses. Electron microscopy achieves nanometer-scale resolution, revealing ultrastructures like viral capsids or bacterial flagella. Colonial forms and biofilms represent adaptive aggregates; bacterial colonies form visible clusters via extracellular matrix secretion, while biofilms encapsulate cells in polysaccharide-protein matrices, enhancing resistance to and antimicrobials. These structures, often millimeters in extent, emerge from coordinated and signaling among cells of the same or different .

Cellular Organization and Metabolism

Prokaryotic microorganisms, encompassing and , feature a simple cellular organization without a membrane-bound nucleus or organelles. Their consists of a single circular housed in the , alongside smaller plasmids, and protein synthesis occurs on 70S ribosomes dispersed in the . Bacterial cell walls incorporate , a cross-linked of and N-acetylmuramic acid that confers rigidity and shape, enabling survival under osmotic stress. In contrast, archaeal cell walls utilize pseudomurein, substituting N-acetyltalosaminuronic acid for muramic acid and lacking peptide cross-links, rendering them resistant to and certain antibiotics targeting . Eukaryotic microorganisms, including protists, yeasts, and microscopic , exhibit compartmentalized structures with a -bound nucleus containing multiple linear chromosomes organized by histones. Specialized organelles enhance metabolic efficiency: mitochondria, originating from endosymbiotic approximately 1.45 billion years ago, house the for ATP production via proton gradient-driven synthesis. This endosymbiosis is evidenced by mitochondrial possession of circular DNA, 70S ribosomes, and a double , mirroring bacterial traits. Some eukaryotic microbes also harbor chloroplasts from cyanobacterial endosymbionts, facilitating . Microbial metabolism fundamentally revolves around redox reactions capturing energy from electron donors to drive ATP synthesis and carbon assimilation. Phototrophs like cyanobacteria perform oxygenic photosynthesis, using photosystem II to oxidize water (2H₂O → O₂ + 4H⁺ + 4e⁻), generating oxygen and reducing NADP⁺ for CO₂ fixation via the Calvin cycle, a process foundational to aerobic Earth's biosphere. Chemolithotrophs extract energy by oxidizing inorganic substrates such as NH₃ to NO₂⁻ or H₂S to SO₄²⁻, coupling this to ATP production through chemiosmosis, often in environments devoid of organic carbon. Fermentation and anaerobic respiration predominate in oxygen-scarce niches, yielding 2 ATP per glucose via glycolysis and organic end-products like lactate or ethanol, underscoring that microbial energetics prioritize substrate availability over oxygen dependence, with anaerobes comprising the majority of Earth's microbial biomass. This diversity reflects thermodynamic imperatives: exergonic catabolism funds endergonic biosynthesis, adapted across redox gradients without reliance on O₂ as the universal acceptor.

Taxonomy and Diversity

Prokaryotic Domains

The prokaryotic domains, and , represent the two primary lineages of cellular life lacking nuclei, distinguished through molecular phylogenetic analyses of (rRNA) sequences. In 1977, and conducted a comparative analysis of 16S rRNA, identifying three major evolutionary branches: eubacteria (now ), archaebacteria (), and eukaryotes, thereby establishing domains as the highest based on genetic divergence rather than superficial traits like cell size or staining properties. This rRNA-based phylogeny prioritizes shared genetic heritage, revealing as more closely related to eukaryotes in informational processing genes despite prokaryotic cellular organization. Bacteria encompass a vast array of metabolically versatile microbes, capable of autotrophy via or , as well as heterotrophy, with cell walls typically featuring polymers. Gram-positive bacteria retain stain due to thick layers (20-80 nm), forming a monoderm structure, whereas Gram-negative bacteria possess thin (2-7 nm) overlaid by an outer membrane containing lipopolysaccharides, which influences susceptibility and pathogenicity. , a Gram-negative , exemplifies bacterial diversity as a , enabling foundational studies in replication, transcription, and owing to its 20-minute generation time and well-mapped of approximately 4.6 million base pairs. Archaea exhibit biochemical adaptations suited to harsh conditions, including lipids with bonds linking branched isoprenoid chains to glycerol-1-phosphate, enhancing thermal and chemical stability absent in bacterial ester-linked fatty acids. Methanogenic archaea, such as those in the order Methanosarcinales, reduce CO₂ or acetate to using nickel-containing cofactors like coenzyme M and F₄₃₀, contributing to global carbon cycling and comprising up to 10% of human . Genomic surveys continue to uncover archaeal innovations, such as a 2024-identified complex enabling de novo production in select lineages, bridging gaps in understanding their .

Eukaryotic Microbes

Eukaryotic microbes are unicellular organisms possessing a membrane-bound nucleus and membrane-enclosed organelles, distinguishing them from prokaryotes through enhanced cellular compartmentalization that supports advanced metabolic and regulatory functions. This structural complexity enables processes like and targeted organelle interactions, absent in and . They span diverse lineages, including protists, unicellular fungi, and , occupying niches from free-living saprophytes to obligate parasites. Protists represent a paraphyletic assemblage of mostly unicellular eukaryotes, excluding plants, animals, and fungi, with forms exhibiting phagotrophy via using , as in , which engulfs bacteria and small eukaryotes for nutrient acquisition. , such as , propel themselves and capture prey using coordinated cilia, achieving speeds up to 1 mm/second in aqueous environments. Parasitic protists like , an apicomplexan, invade host erythrocytes through gliding motility powered by actin-myosin motors, completing a life cycle that alternates between and hosts, with merozoite stages multiplying asexually to densities exceeding 10^12 parasites per infected individual. Unicellular fungi, including yeasts like and filamentous molds such as , feature rigid cell walls composed primarily of and glucans, providing osmotic stability in hypotonic environments. These organisms rely on osmotrophy, externally digesting complex polymers via secreted hydrolases like cellulases and then absorbing monomeric sugars, enabling decomposition of lignocellulosic materials at rates up to 50% mass loss per week under optimal conditions. Yeasts reproduce asexually by , generating daughter cells that inherit cytoplasmic components through asymmetric division. Unicellular algae, exemplified by the green alga , perform oxygenic using chloroplasts containing membranes with I and II, fixing CO2 at efficiencies rivaling higher plants, up to 10% of incident solar energy under laboratory conditions. These microbes dominate biomass in freshwater and marine ecosystems, contributing over 50% of global through rapid division cycles, doubling every 8-12 hours in nutrient-replete media. Slime molds, such as cellular species in the Dictyosteliida (e.g., Dictyostelium discoideum), transition from solitary amoebae feeding on via to multicellular aggregates under starvation, forming slug-like structures up to 2 mm long that migrate toward light and heat before culminating in spore-bearing fruiting bodies, with aggregation mediated by cyclic AMP signaling pulses propagating at 300 micrometers per minute. This facultative multicellularity highlights adaptive plasticity in eukaryotic microbes, contrasting rigid unicellularity in other protists while remaining fundamentally amoeboid.

Viruses and Borderline Entities

Viruses are acellular infectious agents composed of a nucleic acid genome encased in a protective protein capsid, devoid of ribosomes, metabolic enzymes, or independent energy production. Their genomes, which can be single- or double-stranded DNA or RNA, vary in size from a few kilobases to over 1 megabase in rare cases, but always lack the cellular architecture essential for autonomous replication. This structure enables viruses to serve as vectors for genetic material transfer but underscores their parasitic reliance on host cells, contrasting with the self-contained causal agency of microbial cells that maintain homeostasis and metabolism via lipid membranes and organelles. The Baltimore classification system delineates seven viral groups based on genome type and the molecular strategy for generating messenger RNA (mRNA) from the viral nucleic acid, reflecting diverse evolutionary adaptations to host transcription machinery. Group I includes double-stranded DNA viruses that directly transcribe mRNA using host RNA polymerase; Group II covers single-stranded DNA viruses that first convert to double-stranded intermediates; Groups III and IV encompass double- and single-stranded RNA viruses, respectively, with the latter relying on viral RNA-dependent RNA polymerases; Group V features negative-sense RNA viruses requiring transcription to positive-sense mRNA; Group VI involves retroviruses with RNA genomes reverse-transcribed to DNA; and Group VII comprises double-stranded DNA viruses using RNA intermediates for replication. This framework highlights viruses' opportunistic exploitation of host biochemistry rather than independent informational processing. Viral replication occurs exclusively within host cells through two primary cycles: the , where the viral genome commandeers host resources to produce progeny virions that burst the cell, releasing up to hundreds of particles; and the , in which the viral genome integrates into the host as a prophage or episome, propagating passively during host division until induction triggers lytic production. Lysogeny facilitates via transduction, where viral packaging errors incorporate host DNA fragments, disseminating genes such as antibiotic resistance determinants across bacterial populations upon subsequent infection. These cycles exemplify viruses' role as non-autonomous replicators, amplifying without intrinsic growth or maintenance capabilities. Giant viruses, such as , challenge traditional size-based distinctions between viruses and microbes, featuring icosahedral capsids approximately 500 nm across with fibril extensions yielding overall diameters up to 750 nm—larger than many small —and genomes of 1.2 megabases encoding over 900 proteins, including translation components. Despite this complexity, they remain acellular and host-dependent, replicating in amoebal factories without independent metabolism. , exemplified by Sputnik infecting , are diminutive dsDNA viruses (50-75 nm particles, 17-30 kb genomes) that parasitize these factories, hijacking giant virus replication machinery to produce their own progeny while often attenuating the primary infection. Such entities blur viral boundaries but reinforce the core criterion of . Debates on viral "aliveness" hinge on the absence of metabolic and , as viruses cannot generate energy, synthesize proteins, or maintain structural integrity extracellularly, functioning instead as inert genetic parcels until invading a host. From a causal realist perspective, this dependency precludes viruses from qualifying as , which require integrated cellular processes for independent propagation and adaptation; they resemble more akin to plasmids than microbes, influencing through host-mediated dynamics rather than intrinsic agency. Empirical evidence from structural and genomic analyses supports classifying viruses and their satellites as borderline replicators within , integral to understanding genetic flow but distinct from cellular life's self-sustaining .

Evolutionary Biology

Origins and Deep Phylogeny

The (LUCA) represents the hypothetical progenitor from which all extant life descends, reconstructed through of conserved genes across domains. Recent phylogenetic analyses, integrating molecular clocks and fossil calibrations, estimate LUCA's existence around 4.2 billion years ago, shortly after Earth's formation and the cessation of the . This entity likely possessed a membrane-bound , basic metabolic pathways for anaerobic chemotrophy, and thermophilic adaptations, including reverse gyrase enzymes indicative of high-temperature habitats. Genomic reconstructions suggest LUCA inhabited hydrogen-rich environments, such as alkaline hydrothermal vents, where geochemical gradients could drive primitive energy conservation via proton motive force, aligning with first-principles of chemical disequilibria fostering formation. Fossil evidence corroborates early prokaryotic diversification post-LUCA, with —layered microbial mats formed by cyanobacteria-like organisms—providing the oldest direct traces of photosynthetic prokaryotes. These structures, dated to approximately 3.5 billion years ago in formations like those in Western Australia's region, exhibit biogenic laminations and isotopic signatures (e.g., depleted δ¹³C) consistent with cyanobacterial activity, predating atmospheric oxygenation. Earlier potential microfossils and carbon isotopic anomalies push microbial activity to 3.7-3.8 billion years, though debates persist over abiotic origins; however, replicated morphologies across sites strengthen biogenicity claims for prokaryotic precedence. Deep phylogeny from and protein sequences further delineates bacterial and archaeal divergences near LUCA, with genomic fossils revealing shared informational genes amid domain-specific operational innovations. Eukaryotic microbes emerged later via endosymbiosis, wherein an was engulfed by an archaeal-like host, evolving into mitochondria and enabling . Phylogenetic analyses of mitochondrial genomes cluster them robustly with , supported by shared structures, membrane lipid biosynthesis pathways, and codon usage biases. This event, estimated 1.8-2.0 billion years ago based on fossil-calibrated clocks and relic plastid data, underscores causal realism in acquisition driving eukaryotic complexity, distinct from prokaryotic lineages. Preceding LUCA, the hypothesis posits self-replicating RNA molecules as informational and catalytic precursors, tested through evolution. Laboratory selections have yielded RNA polymerases capable of template-directed synthesis and ligation, with fidelities approaching biological thresholds under prebiotic conditions, though challenges remain in achieving full autonomy without protein aid. -mediated formation and experiments provide empirical support, yet genomic parsimony favors RNA-to-DNA transitions post-LUCA, as universal components imply primacy in early replication.

Horizontal Gene Transfer Dynamics

Horizontal gene transfer (HGT) in microorganisms refers to the non-vertical movement of genetic material between cells, distinct from parent-to-offspring inheritance, enabling rapid acquisition of adaptive traits such as antibiotic resistance genes. This process occurs primarily through three mechanisms: transformation, involving the uptake of free DNA from the environment by competent cells; conjugation, a direct cell-to-cell transfer mediated by conjugative plasmids and type IV secretion systems; and transduction, where bacteriophages package and deliver host DNA to new recipients. Plasmids serve as key vectors in conjugation, often carrying accessory genes that confer selective advantages, including multidrug resistance cassettes that spread rapidly in clinical and environmental settings. Empirical genomic analyses indicate that 10-20% of protein-coding genes in many bacterial genomes originate from HGT events, with higher proportions in pathogens exposed to anthropogenic pressures like antibiotics. For instance, in Escherichia coli, HGT contributes to metabolic versatility and virulence factors, allowing colonization of diverse niches without relying solely on de novo mutations. While HGT facilitates evolvability by importing pre-evolved functional modules, microbial defenses such as CRISPR-Cas systems counter incoming DNA, particularly during transduction, by acquiring spacers from invaders for sequence-specific cleavage. However, spacer acquisition rates in natural populations are low, with gut rarely updating arrays despite phage exposure, limiting the efficacy of this barrier and permitting persistent HGT flows. reveals HGT accelerates beyond mutation-selection alone, as transferred alleles establish at low frequencies but confer immediate fitness gains in dynamic environments, such as heavy metal-contaminated soils or host immune pressures. In extremophiles, HGT-mediated acquisition of stress-response genes outpaces vertical , enabling in habitats like acidic mines or hypersaline lakes where mutation rates alone prove insufficient. This mechanism underpins the mosaic genomes observed in prokaryotes, where core vertical inheritance integrates horizontally sourced innovations for enhanced resilience.

Adaptive Radiations and Speciation

Adaptive radiations in microorganisms involve the rapid diversification of lineages into unoccupied ecological niches, often triggered by environmental upheavals or metabolic innovations that enable exploitation of previously inaccessible resources. Unlike macroorganisms, microbial radiations frequently manifest through physiological adaptations to physicochemical gradients, such as shifts in or substrate availability, rather than morphological changes. from genomic and records indicates that these events proceed at accelerated rates due to short generation times and high rates, with diversification bursts quantifiable in terms of emergence over geological timescales. Following the Permian-Triassic mass extinction event around 252 million years ago, which eliminated over 90% of marine species, microbial assemblages exhibited opportunistic blooms and diversification into vacated niches. Microbialites—stromatolite-like structures dominated by and other prokaryotes—proliferated in shallow marine environments, with palaeogeographic data showing their abundance peaking within 1-2 million years post-extinction, contrasting the 5-10 million year lag in metazoan recovery. This radiation was driven by elevated nutrient fluxes and reduced competition from eukaryotes, fostering niche occupation via sulfate-reducing bacteria and photosynthetic microbes adapted to anoxic conditions. In contemporary settings like biofilms, environmental pressures enforce niche partitioning that underpins speciation-like divergence. Within layered microbial mats or seam biofilms, taxa stratify along oxygen, , and nutrient gradients; for example, aerobic heterotrophs dominate surface layers while anaerobes exploit deeper sulfidic zones, reducing competition and promoting co-occurrence of distinct metabolic guilds. Succession studies in biofilms reveal quantifiable shifts, with alpha-diversity increasing by up to 50% over periods as spatially segregated communities emerge, driven by respiration-induced matrix formation that stabilizes micro-niches. Allopatric speciation in extremophiles exemplifies isolation-driven , where geographic barriers in disparate habitats prevent dispersal and accumulate genetic differences. Thermoacidophilic from isolated volcanic sites, such as those in Yellowstone or Icelandic hot springs, display metabolic evidence of biogeographic separation, with substrate utilization profiles diverging despite phylogenetic proximity, supporting allopatric origins over panmictic . Isolation in these extreme locales—characterized by temperatures exceeding 80°C and below 3—limits migration, allowing drift and selection to foster incipient species over timescales as short as thousands of years, as inferred from genomic divergence rates. Recent metagenomic surveys underscore ongoing radiations in isolated deep biosphere niches. In 2023, analyses of fluids from deep-sea hydrothermal systems identified novel clades within groups, including two new metagenome-assembled genomes from the Odinbacterium lineage, revealing metabolic specializations for and cycling in oxygen-poor subsurface layers. These discoveries, encompassing uncultured lineages with up to 20% genomic novelty relative to known taxa, highlight how tectonic barriers and low-energy fluxes sustain diversification in Earth's vast, under-explored crustal habitats.

Ecological Significance

Habitats and Extremophily

Microorganisms occupy virtually every conceivable niche on , from surface soils and oceans to the atmospheric boundary layer and lithospheric depths, demonstrating tolerances that far exceed anthropocentric assumptions about life's viability. These habitats span aerobic, anaerobic, oligotrophic, and nutrient-rich conditions, with microbial communities adapting via specialized metabolic pathways and cellular structures that maintain amid fluctuations in temperature, pressure, , , and . Such ubiquity underscores that is not delimited by human physiological constraints but by fundamental physicochemical limits on biochemical stability, including protein denaturation thresholds and membrane integrity. Extremophiles exemplify these adaptations, thriving in environments lethal to mesophilic bulk life forms through mechanisms like heat-stable enzymes, osmoprotectant accumulation, and proton-pumping ion gradients. Thermophiles, with optimal growth above 45°C and hyperthermophiles exceeding 80°C, include Thermus aquaticus, isolated from hot springs in 1966, which exhibits a temperature optimum of 70–80°C for its enzyme. This , purified in 1976, withstands repeated 95°C denaturation cycles without inactivation, enabling the (PCR) technique developed in 1983, which amplified DNA segments for the first time and transformed . Halophiles tolerate NaCl concentrations beyond 15%, up to saturation levels near 30% in environments like the Dead Sea; , an archaeon, maintains turgor via compatible solutes such as potassium ions and employs for phototrophy in oxygen-poor brines. Acidophiles flourish at pH below 3, often in volcanic or mine drainage settings; Acidithiobacillus ferrooxidans oxidizes ferrous iron and sulfur for , sustaining growth at pH 1.5–2.0 via acid-stable outer proteins and reversed cytoplasmic pH gradients. The deep subsurface biosphere represents the largest microbial reservoir, embedding 2.9 × 10^{29} cells in marine sediments alone as of 2020 estimates, potentially comprising 15–20% of Earth's total prokaryotic biomass despite comprising over 70% of the planet's volume. These communities, detected via borehole drilling and isotopic tracers, exhibit metabolic rates reduced by 10^2 to 10^4-fold compared to surface microbes, with doubling times spanning decades to millennia, fueled by and organic carbon from geogenic sources rather than . Such persistence challenges surface-biased models, revealing life's capacity for and opportunistic activation in isolated, energy-starved realms.

Biogeochemical Contributions

Microorganisms drive key biogeochemical transformations through enzymatic processes that convert inert elements into bioavailable forms or vice versa, exerting causal influence on planetary elemental fluxes, including nutrient cycling of carbon, nitrogen, and phosphorus; decomposition of organic matter; soil formation; and climate regulation. In the nitrogen cycle, prokaryotic diazotrophs such as Rhizobium species in symbiotic associations with legumes and free-living cyanobacteria fix atmospheric N₂ into ammonia via nitrogenase, contributing an estimated 90–130 Tg N yr⁻¹ from biotic sources on continents alone, with total global biological nitrogen fixation reaching approximately 200–400 Tg N yr⁻¹ when including marine contributions. This microbial activity sustains primary productivity in nitrogen-limited ecosystems, as evidenced by isotopic tracing in soils and sediments showing diazotroph-derived nitrogen comprising up to 50% of plant uptake in unmanaged systems. Microbial decomposition of organic matter releases nutrients back into ecosystems and contributes to soil organic matter accumulation, which stabilizes soil structure and promotes aggregation through microbial exudates and residues. In the phosphorus cycle, soil microorganisms mediate organic P mineralization via phosphatase enzymes and solubilize insoluble inorganic phosphates through production of organic acids and siderophores, enhancing bioavailability in P-limited environments where abiotic fixation predominates; these processes can supply 50–90% of plant-available P in natural soils. In carbon cycling, marine microorganisms, including prokaryotic cyanobacteria and eukaryotic phytoplankton, account for roughly 50% of global primary production, fixing about 50 Gt C yr⁻¹ via photosynthesis in oceanic environments, where empirical measurements from satellite chlorophyll data and in situ carbon uptake assays confirm their dominance over terrestrial vascular plants in total flux. Methanotrophic bacteria further modulate atmospheric carbon by oxidizing methane to CO₂ and biomass, with global aerobic methanotrophy consuming an estimated 30–50% of produced CH₄, preventing escalation of this greenhouse gas; isotopic signatures (¹³C depletion in sediments) link these bacteria to the remineralization of up to 100 Tg CH₄ yr⁻¹ in oxic layers. Conversely, methanogenic archaea generate methane in anoxic niches, contributing ~100–200 Tg CH₄ yr⁻¹ from natural wetlands, a flux verified by bottom-up inventories and atmospheric inversions, amplifying radiative forcing by 20–30 times that of CO₂ on a per-molecule basis over century scales. Sulfur cycling in sediments relies on microbial oxidation of reduced sulfides (e.g., H₂S from sulfate-reducing ) by chemolithoautotrophs like and colorless bacteria, proceeding at rates three orders of magnitude faster than abiotic oxidation, as quantified in slurry incubations showing turnover times of hours versus days chemically; this prevents sulfide toxicity and recycles , with coastal sediments alone processing equivalents of global sulfate inputs annually. Similarly, iron oxidation by such as Gallionella and Leptothrix in sediments couples Fe(II) to O₂ or nitrate, forming Fe(III) oxides that sorb phosphates and heavy metals, with microbial rates exceeding abiotic by factors of 10–100 in microoxic zones, as demonstrated by and in anoxic-oxic interfaces. These processes maintain redox gradients essential for stratified elemental distributions, with empirical depth profiles revealing microbial mediation of 70–90% of iron turnover in ferruginous sediments.

Symbioses and Microbial Consortia

Symbioses in microorganisms involve stable, often mutualistic associations between species that yield emergent properties exceeding individual capabilities, such as enhanced nutrient acquisition or environmental resilience. Lichens exemplify this as composite organisms formed by ascomycete or basidiomycete fungi symbiotically associated with green algae (primarily Trebouxiophyceae) or cyanobacteria, where the fungal mycobiont provides a protective thallus structure and absorbs water and minerals, while the photobiont performs photosynthesis to supply fixed carbon, enabling survival in harsh terrestrial habitats. This partnership, evolving independently multiple times in fungi around 480 million years ago, demonstrates division of labor and metabolic complementarity, with the consortium exhibiting traits like desiccation tolerance absent in isolated partners. Similarly, scleractinian corals form holobionts with dinoflagellate algae of the genus Symbiodinium (zooxanthellae), which reside intracellularly in gastrodermal cells; the algae supply up to 95% of the coral's energy via translocated photosynthates in exchange for inorganic nutrients like nitrogen and phosphorus from host waste, facilitating reef-building in oligotrophic marine environments. These interactions highlight causal realism in symbiosis, where host-algal metabolic exchanges drive holobiont fitness, though disruptions like thermal stress can lead to uncoupling without implying inherent parasitism under baseline conditions. Microbial consortia extend these dynamics to multi-species communities exhibiting cooperative networks and emergent behaviors through interspecies interactions. In guts, polymicrobial consortia degrade complex dietary fibers—polysaccharides like and indigestible by host enzymes—via sequential : primary degraders such as Bacteroides thetaiotaomicron hydrolyze polymers into oligosaccharides, which cross-feed secondary fermenters like species to produce (SCFAs) such as , propionate, and butyrate, totaling up to 10% of human caloric intake and modulating host epithelial integrity. This cross-feeding exemplifies causal chains in consortia, where metabolic byproducts from one enable another's function, yielding community-level properties like efficient energy extraction from recalcitrant substrates; empirical metagenomic data from human fecal samples confirm Bacteroidetes and Firmicutes dominance in fiber , with consortium stability linked to interactions rather than stochastic assembly. Quorum sensing (QS) underpins coordination in bacterial consortia, particularly biofilms, where diffusible autoinducers accumulate to threshold levels, triggering population-density-dependent gene expression for collective behaviors. In Gram-negative bacteria like Pseudomonas aeruginosa, N-acyl homoserine lactones (AHLs) signal high cell density to upregulate exopolysaccharide matrix production, adhesins, and efflux pumps, forming structured biofilms with emergent antibiotic tolerance up to 1,000-fold higher than planktonic cells due to diffusion barriers and metabolic heterogeneity. QS circuits, conserved across proteobacteria, enable phase transitions from solitary growth to communal states, as biophysical models show signaling efficiency scales with biofilm density gradients, preventing premature activation in dilute environments. These mechanisms reveal first-principles of microbial sociality, where individual signaling yields group-level resilience, observed in natural consortia like dental plaques or engineered systems. Synthetic microbial consortia, rationally assembled from defined strains, harness these principles for targeted applications, demonstrating superior performance over monocultures through programmed interactions. In , engineered consortia degrade recalcitrant pollutants like polychlorinated biphenyls (PCBs) or polycyclic aromatic hydrocarbons (PAHs) via modular pathways: for instance, - pairings where one strain initiates ring cleavage and another handles , achieving 80-95% removal rates in contaminated sediments within 30 days, compared to 40-60% for single species. Empirical validation from lab-scale trials confirms emergent stability from cross-protection and nutrient shuttling, with tools like quorum-sensing modules ensuring spatiotemporal control; a 2022 consortium of variants targeted breakdown, mineralizing 90% in soil microcosms via sequential dealkylation and hydrolysis steps. Such designs underscore causal engineering of consortia, prioritizing verifiable metabolic fluxes over untested natural analogs for scalable .

Practical Applications

Biotechnology and Industrial Uses

Microorganisms play a central role in industrial processes, enabling the large-scale production of food and beverages through metabolic conversions. In production, such as and Streptomyces thermophilus ferment in into , resulting in acidification, , and the characteristic texture and flavor; this process has been industrialized since the early 20th century, with global output exceeding 10 million tons annually by 2020. Similarly, yeasts like drive by converting fermentable sugars into and , a practice scaled industrially to produce over 1.9 billion hectoliters worldwide in 2023, enhancing efficiency through strain selection and controlled s that reduce production time from weeks to days. These fermentation capabilities extend to antibiotics such as penicillin produced by Penicillium species, biofuels including bioethanol from yeasts and bacteria, vitamins like B12 from microbial cultures, and various pharmaceuticals, harnessing metabolic pathways for sustainable synthesis. Recombinant DNA technology has revolutionized microbial by engineering bacteria for high-value protein production. In 1982, the U.S. approved Humulin, the first commercially produced , synthesized in genetically modified Escherichia coli bacteria via insertion of the human insulin gene into plasmids, enabling scalable yields of up to 7 grams per liter in fermenters and replacing animal-derived insulin to meet rising demands with purities over 98%. This approach exemplifies efficiency gains, as microbial hosts like and achieve rapid growth rates (doubling times of 20-30 minutes) and genetic tractability, reducing costs by orders of magnitude compared to extraction methods. Microbial enzymes further demonstrate industrial utility, with amylases derived from bacteria such as and widely used in detergents to catalyze the of starch-based stains at alkaline pH and moderate temperatures, improving cleaning efficacy by 20-30% in laundry formulations while enabling lower washing temperatures to save energy. These thermostable enzymes, produced via submerged yielding thousands of tons annually, maintain activity in the presence of and oxidants, outperforming chemical alternatives in specificity and biodegradability. Recent advancements in microbial engineering target terpenoids, a class of natural products valued for pharmaceuticals and fragrances. In 2024, enzyme engineering strategies in hosts like Saccharomyces cerevisiae and Escherichia coli optimized terpene synthases and prenyltransferases, boosting titers of complex terpenoids such as astaxanthin and taxadiene by over 10-fold through pathway modularization and cofactor balancing, facilitating sustainable bioproduction from cheap feedstocks like glucose at scales competitive with plant extraction. These innovations underscore causal efficiencies in microbial systems, where directed evolution and CRISPR-based edits minimize byproducts and maximize flux, yielding economic viabilities projected at under $10 per kilogram for high-value terpenoids by 2030.

Environmental and Agricultural Roles

Microorganisms contribute significantly to via , where naturally occurring or augmented populations degrade pollutants. Following the on March 24, 1989, which released approximately 11 million gallons of crude oil into , , —through the addition of nitrogen and phosphorus fertilizers—enhanced the activity of indigenous hydrocarbon-degrading bacteria, including Pseudomonas species, accelerating the breakdown of and polynuclear aromatic hydrocarbons by up to 70% in treated shorelines compared to controls. Pseudomonas strains, such as P. aeruginosa and P. putida, produce biosurfactants and enzymes like alkane hydroxylases that emulsify and oxidize components, making this a cornerstone of strategies for oil-contaminated sites. In agricultural contexts, soil microorganisms enhance fertility and productivity, with a single gram of fertile harboring 10^9 to 10^10 bacterial cells alongside fungi, , and other microbes that drive . These decomposers, particularly and fungi, mineralize plant residues at rates positively correlated with microbial diversity, releasing nutrients like and while preventing accumulation of undecayed litter that could tie up resources. Nitrogen-fixing bacteria such as Rhizobium in symbiosis with legumes convert atmospheric N2 into ammonia, providing 100-300 kg N/ha annually; phosphate-solubilizing microbes like Bacillus and Pseudomonas release bound phosphorus via acid production, enhancing availability by 20-50%; plant growth-promoting rhizobacteria produce hormones and siderophores to boost root growth and nutrient uptake, increasing yields by 10-25%; these functions underpin biofertilizers that reduce chemical inputs for sustainable productivity. Arbuscular mycorrhizal fungi (AMF), symbiotic with over 80% of terrestrial , function as biofertilizers by extending root hyphae to improve uptake—often doubling acquisition efficiency—and boosting yields by an average of 23% under rainfed conditions across 13 major crops, reducing reliance on chemical fertilizers. Despite these benefits, microbial interventions pose risks, including unintended ecological disruptions and the spread of antibiotic resistance genes (ARGs). Bioaugmentation with hydrocarbon-degraders in petroleum remediation can inadvertently mobilize ARGs via , potentially disseminating resistance from introduced strains to native populations and complicating future antibiotic efficacy in environmental and clinical settings. In , over-reliance on microbial inoculants like AMF may select for resistant microbial variants or alter consortia, leading to imbalances that reduce long-term decomposition efficiency or exacerbate pressures if native is supplanted. Such cons underscore the need for site-specific assessments to balance remediation gains against potential and community shifts.

Medical and Therapeutic Exploits

Microorganisms have been harnessed for producing recombinant therapeutic proteins, such as human insulin, via genetically engineered bacteria like Escherichia coli or yeast such as Saccharomyces cerevisiae, enabling large-scale fermentation and purification for diabetes treatment since the 1980s. This approach replaced animal-derived insulin, reducing immunogenicity risks and improving supply consistency, with E. coli systems yielding high expression levels from inclusion bodies processed downstream. Similarly, microbes serve as platforms for other biologics, including growth factors and enzymes, though challenges like protein folding in prokaryotes necessitate hybrid systems with eukaryotic hosts for glycosylation. Live attenuated vaccines, derived from weakened pathogenic microorganisms, elicit robust, long-lasting immunity; examples include the Sabin vaccine, which achieved near-eradication in vaccinated populations with exceeding 99% against paralytic after multiple doses. Bacterial instances, such as the from attenuated , demonstrate 50-80% against severe tuberculosis forms in children, though variable protection against pulmonary in adults highlights causal limitations tied to strain-host interactions rather than universal . These vaccines mimic natural without causing , but trial data underscore risks like reversion to in immunocompromised individuals, as seen in rare oral polio vaccine-associated paralytic cases (1-2 per million doses). Probiotic formulations using strains reduce acute duration by approximately 25 hours in children, per meta-analyses of randomized trials, with reductions of 20-52% for antibiotic-associated cases, though efficacy varies by strain and host factors, showing no benefit in some persistent subsets. Causal mechanisms involve exclusion and immune modulation, but over-reliance on commercial strains risks inconsistent outcomes, as evidenced by non-significant effects in certain meta-analyses. Fecal microbiota transplantation (FMT) restores gut microbial consortia, achieving 80-90% resolution rates for recurrent Clostridioides difficile infection after antibiotics fail, with single-treatment success at 75% rising to 87% upon repetition in refractory cases. This therapy outperforms fidaxomicin in preventing relapse by reestablishing colonization resistance, yet risks include transient bacteremia (1-4% incidence) and undefined donor screening protocols, emphasizing empirical validation over microbiome diversity assumptions. Bacteriophage therapy targets antibiotic-resistant infections, with compassionate-use cases and trials reporting microbiological clearance in 70-90% of multidrug-resistant Pseudomonas or Staphylococcus episodes, as in a 2023 review of 59 interventions showing reduced bacterial loads without systemic toxicity. Ongoing trials for Klebsiella pneumoniae pneumonia (2019-2023) confirm efficacy in ventilator-associated cases, but phage resistance emergence in 20-30% of treated sites necessitates cocktails, balancing specificity against adaptive bacterial countermeasures. Regulatory hurdles persist, with no broad U.S. approvals by 2025, relying on expanded-access protocols amid variable trial endpoints.

Health and Pathogenicity

Commensal and Mutualistic Interactions

Commensal microorganisms inhabit host surfaces and cavities, deriving nutrients without harming the host, while mutualistic interactions confer benefits to both parties, such as nutrient provision or immune modulation. In the human gut, the microbiome comprises hundreds to thousands of bacterial species, with estimates ranging from 300 to over 1,000 distinct taxa in the colon, dominated by Firmicutes and Bacteroidetes phyla. These microbes synthesize essential vitamins unavailable from human metabolism, including vitamin K via species like Bacteroides and Escherichia coli, and vitamin B12 by certain anaerobes, supporting host coagulation and neurological function. Additionally, gut microbes aid digestion by fermenting indigestible dietary fibers into short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, which provide energy to colonocytes and contribute to gut barrier integrity. The gut microbiota also trains the host , promoting maturation of and regulatory T cells to maintain tolerance and prevent overreactions. Germ-free mice, lacking microbial colonization, exhibit underdeveloped Peyer's patches, reduced IgA production, and impaired T-cell differentiation, underscoring the causal role of commensals in immune . On skin and oral surfaces, commensal bacteria like produce that inhibit pathogen adhesion and growth, providing colonization resistance against invaders such as Staphylococcus aureus or cariogenic streptococci. The posits that diminished early-life microbial exposure disrupts this training, elevating risks of allergic diseases and , as evidenced by lower prevalence among farm-raised children exposed to livestock-associated microbes compared to urban peers. Cohort studies, including the GABRIELA project, report 25-50% reduced odds of in farm environments, attributing protection to diverse airborne and fungal elements fostering microbial diversity. Dysbiosis, or imbalances in the microbiome, has been implicated in diseases including inflammatory bowel disease (IBD), certain cancers, and autoimmune conditions. These interactions highlight microorganisms' predominant non-pathogenic roles, countering historical emphases on disease causation by revealing their integral contributions to host and resilience.

Infectious Diseases Causation

The causation of infectious diseases by microorganisms is established through fulfillment of , formulated by in the late 19th century as criteria to link specific microbes to particular diseases: the microorganism must be found in abundance in all cases of the disease but absent in healthy hosts; it must be isolated and grown in pure culture; inoculation of the pure culture into a healthy susceptible host must reproduce the disease; and the same microorganism must be re-isolated from the experimentally infected host. These postulates provide a rigorous framework for , emphasizing empirical demonstration over mere correlation, though adaptations are necessary for unculturable pathogens or ethical constraints in human experimentation. For molecular mechanisms of pathogenicity, Stanley Falkow's molecular Koch's postulates extend this framework to virulence factors, requiring that alteration of a suspected gene or its product consistently affects disease outcome in a predictable manner, such as increased virulence upon gain-of-function or attenuation upon loss-of-function in animal models. A prime example is Vibrio cholerae, where the cholera toxin (CT), an AB5 toxin encoded by the CTX phage, is the primary virulence factor causing massive secretory diarrhea by elevating cyclic AMP in intestinal cells, leading to fluid loss; strains lacking CT fail to produce severe disease, fulfilling molecular criteria. Adhesins like the toxin-coregulated pilus (TCP) further enable colonization, underscoring how specific microbial products drive pathogenesis. Transmission modes critically influence disease causation, with pathogens exploiting routes like airborne dissemination via respiratory droplets for viruses such as the 1918 H1N1 , or fecal-oral pathways for enteric like V. cholerae through contaminated water. The 1918 influenza pandemic exemplifies microbial causation on a global scale, infecting one-third of the world's population and causing approximately 50 million deaths worldwide, with high mortality in young adults due to storms triggered by . In contrast, modern interventions have controlled similar outbreaks, highlighting causality while revealing variability in outcomes. Host factors modulate susceptibility and severity, integrating with microbial agents in causal realism; empirical evidence shows nutritional deficiencies, such as , impair and increase infection risk, as seen in heightened susceptibility among undernourished populations. Immune competence, influenced by factors like status (e.g., or ), alters clearance, where deficient states elevate microbial burden without altering the pathogen's intrinsic causality, as demonstrated in controlled studies linking undernutrition to prolonged and secondary bacterial infections. Thus, while microorganisms are necessary and sufficient under postulates, host terrain—encompassing and immunity—determines epidemiological impact.

Resistance Mechanisms and Public Health Challenges

Bacteria employ diverse mechanisms to resist antibiotics, including enzymatic degradation and active expulsion of drugs. Beta-lactamases, enzymes produced by many gram-negative and gram-positive bacteria, hydrolyze the beta-lactam ring in antibiotics like penicillins and cephalosporins, rendering them inactive; this is a primary resistance strategy against beta-lactams in pathogens such as and . Efflux pumps, membrane proteins that actively transport antibiotics out of bacterial cells, contribute to multidrug resistance by reducing intracellular drug concentrations; these pumps, often of the resistance-nodulation-division (RND) family, affect a broad range of compounds including beta-lactams and fluoroquinolones in species like . Horizontal gene transfer via plasmids further disseminates these resistance determinants across microbial populations, accelerating the spread beyond mutational evolution. Antimicrobial resistance (AMR) imposes severe public health burdens, with bacterial AMR directly causing 1.27 million deaths globally in 2019 and associating with nearly 5 million more, per WHO estimates; updated analyses indicate 1.14 million attributable deaths in 2021, with projections of 39 million deaths from resistant infections by 2050 if trends persist. Empirical drivers include overuse in human medicine—such as unnecessary prescriptions for viral illnesses—and in , where s promote livestock growth, selecting for resistant strains that enter human food chains; U.S. veterinary antibiotic sales exceeded 20 million kilograms annually as of recent data, correlating with elevated resistance in enteric pathogens. These patterns reflect causal selective pressures rather than mere , as subtherapeutic dosing in farming fosters low-level resistance that amplifies under clinical exposure. Antibiotic stewardship programs, emphasizing prospective audit and targeted restrictions in hospitals, have empirically reduced usage and resistance rates; meta-analyses show 10-30% drops in prescriptions and up to 28% in overall consumption in high-income settings, with some interventions achieving 50% reductions in inappropriate prescribing for specific scenarios like community visits. Such data-driven approaches, prioritizing and rapid susceptibility testing over blanket mandates, mitigate overuse without undermining care access; however, agricultural reforms lag, as voluntary guidelines yield inconsistent compliance compared to enforced veterinary oversight. Emerging alternatives address over-reliance on novel pharmaceuticals, which face development hurdles due to economic disincentives. therapy, using viruses that lyse specific , shows promise in compassionate-use cases and phase I/II trials for multidrug-resistant infections like those from , evading broad-spectrum disruption of unlike antibiotics. Vaccines targeting resistant pathogens, such as pneumococcal conjugates, reduce infection incidence upstream, while 2023 multiplex PCR assays enable detection of 24+ resistance genes in hours, guiding precise therapy and curbing empirical broad-spectrum use in urinary tract infections. These tools favor individualized, evidence-based responses over population-level interventions, countering pharma-centric models that prioritize high-volume drugs amid stagnant pipeline innovation since 2017.

Controversies and Critical Perspectives

Debates on Vitalism vs. Mechanism

, the doctrine asserting that living entities including microorganisms possess a non-physical vital force beyond mechanistic physical and chemical processes, historically clashed with emerging empirical . In the context of microorganisms, manifested prominently in the theory of , which held that microbes arose directly from non-living matter without parental precursors. 's 1861 swan-neck flask experiments refuted this by boiling nutrient broth in flasks with elongated, curved necks that trapped airborne dust while allowing air exchange; untouched flasks remained sterile, while necks broken to permit dust entry led to microbial growth, demonstrating contamination by pre-existing germs rather than . These results, presented to the in 1864, aligned microbial origins with mechanistic reproduction from parent microbes, eroding vitalist explanations for life processes. Robert Koch advanced this mechanistic paradigm through postulates formulated in 1884 with Friedrich Loeffler and published in 1890, establishing criteria for microbial disease causation: the pathogen must be found in diseased but not healthy hosts, isolated and grown in pure culture, cause the same disease when inoculated into healthy animals, and be re-isolated from the infected host. Applied to (1876) and (1882), these falsified host-only models—such as those emphasizing vital forces or internal imbalances alone—by reproducibly inducing disease in healthy subjects via isolated microbes, independent of host predisposition. Koch's framework shifted causality to specific microbial agents, enabling predictions verified in controlled inoculations that contradicted vitalist claims of irreducible life forces. Echoes of persist in fringe terrain theory, which posits disease arises solely from host "terrain" derangements rather than microbial pathogens, as contended by (1816–1908) against Pasteur's germ causality. Empirical tests undermine this: terrain predictions of infection immunity in optimized hosts fail, as evidenced by uniform disease induction in healthy animals per Koch's methods, and lack alternative interventions matching germ theory's successes like sterilization and . Terrain advocates' dismissal of transmission evidence ignores efficacy in epidemics, where microbial isolation prevents spread regardless of host variability, affirming mechanism over non-empirical host centrism.

Microbiome Research Limitations

Microbiome research has generated significant enthusiasm for its potential to explain health outcomes, yet empirical limitations undermine many claims, particularly in distinguishing signal from noise in complex datasets. Low-biomass environments, such as , are especially vulnerable to from laboratory reagents, , and environmental sources, leading to artifactual detections rather than true resident microbes. A 2023 study analyzing over 9,000 blood samples from healthy individuals using multiple sequencing methods found no consistent for a core blood microbiome, attributing reported signals to background contamination rather than viable communities. Similarly, reviews from the same year highlight that undetermined viability of detected sequences further complicates interpretations, as non-viable DNA fragments can mimic active microbial presence. Common misconceptions exacerbate interpretive errors, including the outdated notion that bacteria vastly outnumber human cells in the body. Early estimates claimed a 10:1 ratio of microbial to human cells, but refined counts based on improved anatomical and genomic data indicate a near 1:1 ratio, with human cells predominating due to larger erythrocytes and overlooked tissue contributions. This overcounting myth, perpetuated in popular literature, inflates perceptions of microbial dominance and fuels unsubstantiated causal extrapolations. In disease contexts like obesity, associations between gut dysbiosis and body mass index abound, but causal evidence remains tenuous, relying predominantly on observational correlations rather than mechanistic interventions. A 2023 review concluded that while animal models suggest microbial influences on energy harvest, human data fail to establish a direct contribution to obesity development, lacking prospective trials isolating microbiota effects from confounders like diet and genetics. Reproducibility poses a systemic barrier, with inter-laboratory comparisons revealing poor consistency in taxonomic profiles due to variations in sampling, extraction, and sequencing protocols. A 2024 of metagenomic sequencing datasets demonstrated substantial and variability across labs, often exceeding 50% divergence in community composition estimates even for standardized mocks, underscoring the need for rigorous controls. Daily oscillations in host microbiomes and unaccounted pre-analytical factors further amplify this , contributing to a replicability where initial findings rarely hold in independent validations. To advance causal realism, must prioritize randomized controlled trials (RCTs) over associative studies, as correlative shifts in microbial abundance do not imply functionality or intervention efficacy without experimental perturbation and outcome tracking. Recent calls emphasize integrating functional with RCTs to bridge these gaps, avoiding overreliance on cross-sectional surveys prone to reverse causation.

Biosafety and Gain-of-Function Risks

Biosafety levels (BSL) were formalized in the 1970s by the U.S. Centers for Disease Control and Prevention (CDC) and (NIH) in response to recombinant DNA research risks, with the first edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL) published in 1984 outlining four tiers from BSL-1 (basic precautions for low-risk agents) to BSL-4 (maximum containment for exotic agents like ). These levels mandate physical barriers, , and procedural controls to prevent accidental release of microorganisms, yet critiques highlight under-enforcement, with contributing to 67-79% of potential BSL-3 exposures in documented incidents. A review of global laboratory accidents from 2000-2021 identified over 300 reported breaches, including pathogen exposures, underscoring systemic gaps in adherence despite guidelines. Gain-of-function (GoF) research, which enhances microbial transmissibility or to study potential, has intensified debates since the 2011 H5N1 experiments by Ron Fouchier and Yoshihiro Kawaoka, who serially passaged in mammals to achieve in ferrets, raising dual-use concerns over accidental release or misuse. The U.S. imposed a funding moratorium on certain GoF studies involving , , and in 2014, following voluntary pauses by researchers in 2012, which was lifted in 2017 under the HHS Potential Pathogen Care and Oversight (P3CO) Framework requiring enhanced risk-benefit reviews. Proponents argue GoF informs development and surveillance, but empirical evidence of laboratory escapes—such as the 1977 re-emergence of H1N1 , genetically matching 1950s strains absent natural and linked to a Chinese lab vaccine trial mishap—demonstrates tangible risks of global outbreaks from containment failures. Historical precedents amplify these hazards, including the 1979 Sverdlovsk release from a Soviet bioweapons facility, which killed at least 66 via aerosolized , and multiple U.S. lab incidents involving select agents like and SARS-CoV since 2003, totaling hundreds of exposures. While GoF aims to preempt natural threats, critics contend benefits are overstated—natural evolution suffices for prediction—and risks outweigh them given imperfect containment, advocating alternatives like loss-of-function (LoF) studies that disrupt microbial traits to infer mechanisms without creating enhanced pathogens. LoF approaches, applicable to and coronaviruses, enable safer hypothesis testing via while avoiding transmissibility gains, as demonstrated in analyses of impacts without . Ongoing policy scrutiny, including 2024 updates to dual-use research oversight, reflects persistent tensions between advancing microbial knowledge and mitigating escape potentials that could seed engineered pandemics.

References

  1. https://www.nps.gov/common/uploads/teachers/lessonplans/WhatisaMicroorganismActivityGuide.pdf
  2. https://learn.genetics.utah.edu/content/microbiome/intro/
  3. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28OpenStax%29/01%253A_An_Invisible_World/1.03%253A_Types_of_Microorganisms
  4. https://www.energy.gov/science/doe-explainsmicrobiology
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC7189961/
  6. https://www.pnas.org/doi/10.1073/pnas.2503013122
  7. https://www.nature.com/articles/s41392-022-00974-4
  8. https://aithor.com/essay-examples/the-impact-of-microorganisms-on-ecosystems-and-human-health
  9. https://pubmed.ncbi.nlm.nih.gov/15209075/
  10. https://www.gideononline.com/blogs/leeuwenhoek-scientist-who-saw-animalcules/
  11. https://courses.lumenlearning.com/suny-microbiology/chapter/spontaneous-generation/
  12. https://www.britannica.com/biography/Francesco-Redi
  13. https://education.nationalgeographic.org/resource/history-cell-discovering-cell/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC10458164/
  15. https://hekint.org/2018/10/23/van-leeuwenhoeks-discovery-of-animalcules/
  16. https://www.discovermagazine.com/leeuwenhoeks-lucky-break-17587
  17. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28OpenStax%29/03%253A_The_Cell/3.01%253A_Spontaneous_Generation
  18. https://pubmed.ncbi.nlm.nih.gov/17940406/
  19. https://www2.nau.edu/gaud/bio301/content/spngen.htm
  20. https://zeiss-campus.magnet.fsu.edu/print/basics/historical-print.html
  21. https://micro.magnet.fsu.edu/primer/museum/museum1800.html
  22. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2017.01561/full
  23. https://stacks.cdc.gov/view/cdc/37781/cdc_37781_DS1.pdf
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC9027159/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC11617125/
  26. https://www.cdc.gov/mmwr/preview/mmwrhtml/00000222.htm
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC3916274/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC9854334/
  29. https://odin.mdacc.tmc.edu/~jjlee/clinical_trials2008/Greenfield%2C%2520historical%2520highlights%2520of%2520randomized%2520controlled%2520trial.pdf
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC10293828/
  31. https://www.nap.edu/read/10636/chapter/5
  32. https://www.nobelprize.org/prizes/medicine/1945/fleming/biographical/
  33. https://www.ox.ac.uk/news/science-blog/penicillin-oxford-story
  34. https://www.nobelprize.org/prizes/medicine/1945/chain/facts/
  35. https://www.nature.com/articles/nj6921-456a
  36. https://www.nature.com/articles/miledna02
  37. https://www.nobelprize.org/prizes/chemistry/1993/mullis/facts/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC9731379/
  39. https://www.nature.com/articles/s12276-024-01262-7
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC12300337/
  41. https://www.nature.com/articles/nature11234
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC4991899/
  43. https://www.sciencedirect.com/science/article/pii/S0092867416000532
  44. https://scitechdaily.com/sugars-that-glow-could-explain-ocean-carbon-mysteries/
  45. https://www.sciencedaily.com/releases/2025/10/251019120511.htm
  46. https://www.biorxiv.org/content/10.1101/2025.06.09.658588v1
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC7148134/
  48. https://www.sciencedirect.com/science/article/pii/S009286742400833X
  49. https://www.nejm.org/doi/full/10.1056/NEJMoa1205037
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC6139215/
  51. https://jamanetwork.com/journals/jama/fullarticle/2664458
  52. https://www.cell.com/cell/fulltext/S0092-8674%2824%2900955-3
  53. https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/microorganism
  54. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28Boundless%29/01%253A_Introduction_to_Microbiology/1.01%253A_Introduction_to_Microbiology/1.1A%253A_Defining_Microbes
  55. https://microbiologysociety.org/publication/past-issues/what-is-life/article/are-viruses-alive-what-is-life.html
  56. https://bio.libretexts.org/Workbench/General_Biology_I_and_II/05%253A_Unit_V-_Biological_Diversity/5.2%253A_Acellular_Entities_-_Viruses_Prions_and_Viroids
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC4978610/
  58. https://bionumbers.hms.harvard.edu/bionumber.aspx?s=n&v=6&id=113931
  59. https://bionumbers.hms.harvard.edu/bionumber.aspx?id=105603&ver=2
  60. https://www.nature.com/articles/nrmicro2644
  61. https://microbeonline.com/size-of-bacteria/
  62. https://www.ncbi.nlm.nih.gov/books/NBK224751/
  63. https://www.ncbi.nlm.nih.gov/books/NBK8325/
  64. https://www.nature.com/articles/s41598-017-13295-2
  65. https://microbenotes.com/bacterial-sizes-shapes-arrangement/
  66. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28Kaiser%29/Unit_1%253A_Introduction_to_Microbiology_and_Prokaryotic_Cell_Anatomy/2%253A_The_Prokaryotic_Cell_-_Bacteria/2.1%253A_Sizes_Shapes_and_Arrangements_of_Bacteria
  67. https://bio.libretexts.org/Learning_Objects/Laboratory_Experiments/Microbiology_Labs/Laboratory_Exercises_in_Microbiology_%28McLaughlin_and_Petersen%29/01%253A_Introduction_to_Microscopy_and_Diversity_of_Cell_Types/1.01%253A_Introduction
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC7126980/
  69. https://www.nature.com/articles/s41522-021-00251-2
  70. https://journals.asm.org/doi/10.1128/mmbr.00037-15
  71. https://pmc.ncbi.nlm.nih.gov/articles/PMC8559796/
  72. https://www.ncbi.nlm.nih.gov/books/NBK579933/
  73. https://www2.nau.edu/~fpm/bio205/274lect2.htm
  74. https://www.nature.com/scitable/topicpage/the-origin-of-mitochondria-14232356/
  75. https://www.ncbi.nlm.nih.gov/books/NBK9841/
  76. https://www.sciencedirect.com/science/article/pii/S0960982215008891
  77. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/phototrophy
  78. https://science.umd.edu/classroom/bsci424/BSCI223WebSiteFiles/LectureSummaries/SummaryLectures7thru9.htm
  79. https://www.ncbi.nlm.nih.gov/books/NBK7919/
  80. https://www.pnas.org/doi/10.1073/pnas.74.11.5088
  81. https://pmc.ncbi.nlm.nih.gov/articles/PMC4008548/
  82. https://www.ncbi.nlm.nih.gov/books/NBK470553/
  83. https://www.medicalnewstoday.com/articles/gram-positive-vs-gram-negative
  84. https://www.news-medical.net/life-sciences/E-coli-as-a-Model-Organism.aspx
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC9487582/
  86. https://microbenotes.com/archaea-vs-bacteria/
  87. https://www.nature.com/articles/s41396-020-00772-2
  88. https://www.science.org/doi/10.1126/science.758677
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC372904/
  90. https://www.biorxiv.org/content/10.1101/2024.07.05.601840v1
  91. https://www2.tulane.edu/~wiser/protozoology/notes/INTRO.html
  92. https://miller.biology.utah.edu/courses/2015/handouts/lab02.pdf
  93. https://pmc.ncbi.nlm.nih.gov/articles/PMC6850671/
  94. https://www.sciencedirect.com/science/article/pii/S1749461320300269
  95. https://nph.onlinelibrary.wiley.com/doi/abs/10.1046/j.1469-8137.2003.00788.x
  96. https://pubmed.ncbi.nlm.nih.gov/31189738/
  97. https://bio.libretexts.org/Bookshelves/Botany/Botany_%28Ha_Morrow_and_Algiers%29/02%253A_Biodiversity_%28Organismal_Groups%29/2.04%253A_Protists/2.4.02%253A_Heterotrophic_Protists/2.4.2.01%253A_Slime_Molds
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC23686/
  99. https://pmc.ncbi.nlm.nih.gov/articles/PMC7150055/
  100. https://journals.asm.org/doi/10.1128/mmbr.00053-21
  101. https://www.ncbi.nlm.nih.gov/books/NBK493185/
  102. https://www.nature.com/articles/ismej201716
  103. https://www.nature.com/articles/nrmicro.2016.197
  104. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2024.1356711/full
  105. https://pmc.ncbi.nlm.nih.gov/articles/PMC10458455/
  106. https://www.sciencedirect.com/science/article/pii/S0042682214005157
  107. https://www.scientificamerican.com/article/are-viruses-alive-2004/
  108. https://www.science.org/content/article/our-last-common-ancestor-lived-4-2-billion-years-ago-perhaps-hundreds-millions-years
  109. https://whyevolutionistrue.com/2024/07/17/new-paper-puts-the-last-universal-common-ancestor-the-creature-that-gave-rise-to-all-living-things-much-earlier-than-previously-thought-4-2-billion-years/
  110. https://www.nature.com/articles/s41559-024-02461-1
  111. https://www.science.org/content/article/our-last-common-ancestor-inhaled-hydrogen-underwater-volcanoes
  112. https://astrobiology.nasa.gov/news/looking-for-luca-the-last-universal-common-ancestor/
  113. https://pubmed.ncbi.nlm.nih.gov/11538389/
  114. https://www.bbc.com/travel/article/20210117-stromatolites-the-earths-oldest-living-lifeforms
  115. https://astrobiology.nasa.gov/news/oldest-evidence-for-early-life-on-earth-dated-to-at-least-377-billion-years/
  116. https://pmc.ncbi.nlm.nih.gov/articles/PMC6152910/
  117. https://www.nature.com/articles/srep00013
  118. https://www.sciencedirect.com/science/article/pii/S096098221731179X
  119. https://microbiologysociety.org/publication/past-issues/archaea/article/the-symbiosis-that-changed-the-world.html
  120. https://www.salk.edu/news-release/modeling-the-origins-of-life-new-evidence-for-an-rna-world/
  121. https://www.nature.com/articles/464494a
  122. https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.70065
  123. https://pmc.ncbi.nlm.nih.gov/articles/PMC4536854/
  124. https://academic.oup.com/gbe/article/15/6/evad089/7180211
  125. https://www.pnas.org/doi/10.1073/pnas.1915966117
  126. https://cee.mit.edu/bacteria-in-the-human-gut-rarely-update-their-crispr-defense-systems/
  127. https://pmc.ncbi.nlm.nih.gov/articles/PMC7604491/
  128. https://www.sciencedirect.com/science/article/pii/S0022283625004693
  129. https://www.cell.com/trends/microbiology/fulltext/S0966-842X%2825%2900100-3
  130. https://academic.oup.com/femsec/article/99/12/fiad154/7444994
  131. https://www.ecehh.org/research/macro-evolution-in-microorganisms-marine-terrestrial-transitions-as-a-case-study-for-adaptive-radiations-in-bacteria/
  132. https://www.sciencedirect.com/science/article/abs/pii/S0031018217310866
  133. https://www.sciencedirect.com/science/article/abs/pii/S0031018223005175
  134. https://www.nature.com/articles/s41467-021-25711-3
  135. https://www.sciencedirect.com/science/article/pii/S2589004219300112
  136. https://www.cell.com/trends/microbiology/fulltext/S0966-842X%2822%2900219-0
  137. https://www.nature.com/articles/ismej200793
  138. https://pmc.ncbi.nlm.nih.gov/articles/PMC1764937/
  139. https://ami-journals.onlinelibrary.wiley.com/doi/10.1111/1462-2920.16543
  140. https://pmc.ncbi.nlm.nih.gov/articles/PMC10457277/
  141. https://pmc.ncbi.nlm.nih.gov/articles/PMC232952/
  142. https://pmc.ncbi.nlm.nih.gov/articles/PMC4148896/
  143. https://microbenotes.com/microbiology-of-extreme-environments/
  144. https://pmc.ncbi.nlm.nih.gov/articles/PMC4187170/
  145. https://pmc.ncbi.nlm.nih.gov/articles/PMC7499048/
  146. https://www.pnas.org/doi/10.1073/pnas.1203849109
  147. https://ui.adsabs.harvard.edu/abs/1995GBioC...9..235G
  148. https://pmc.ncbi.nlm.nih.gov/articles/PMC3682739/
  149. https://vonfischerlab.colostate.edu/wp-content/uploads/2010/03/Cleveland-etal-BGC-1999-Global-N2-Fixation.pdf
  150. https://www.nature.com/articles/s41467-024-53947-2
  151. https://www.nature.com/articles/s43705-023-00340-7
  152. https://www.sciencedirect.com/science/article/pii/S0078323415000925
  153. https://www.nature.com/articles/s41467-022-35082-y
  154. https://www.globalcarbonproject.org/methanebudget/20/hl-compact.htm
  155. https://asm.org/articles/2022/may/how-methanogenic-archaea-contribute-to-climate-cha
  156. https://www.sciencedirect.com/science/article/abs/pii/B978044452989300009X
  157. https://www.nature.com/articles/s41586-025-09467-0
  158. https://scitechdaily.com/scientists-discover-microbes-that-breathe-iron-to-detoxify-the-planet/
  159. https://pmc.ncbi.nlm.nih.gov/articles/PMC10490544/
  160. https://www.nature.com/articles/s41467-024-48787-z
  161. https://pmc.ncbi.nlm.nih.gov/articles/PMC1636081/
  162. https://pmc.ncbi.nlm.nih.gov/articles/PMC4141621/
  163. https://pmc.ncbi.nlm.nih.gov/articles/PMC7146107/
  164. https://pmc.ncbi.nlm.nih.gov/articles/PMC9787832/
  165. https://pmc.ncbi.nlm.nih.gov/articles/PMC7086079/
  166. https://www.pnas.org/doi/10.1073/pnas.2022818118
  167. https://www.mdpi.com/2073-4441/13/20/2928
  168. https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.1051233/full
  169. https://pmc.ncbi.nlm.nih.gov/articles/PMC10991178/
  170. https://pmc.ncbi.nlm.nih.gov/articles/PMC11719914/
  171. https://pmc.ncbi.nlm.nih.gov/articles/PMC7122484/
  172. https://www.fda.gov/about-fda/fda-history-exhibits/100-years-insulin
  173. https://pmc.ncbi.nlm.nih.gov/articles/PMC8152450/
  174. https://www.creative-enzymes.com/resource/application-of-enzymes-in-detergent-industry_61.html
  175. https://pmc.ncbi.nlm.nih.gov/articles/PMC10235266/
  176. https://pubmed.ncbi.nlm.nih.gov/39174466/
  177. https://www.sciencedirect.com/science/article/abs/pii/S0958166924000351
  178. https://www.princeton.edu/~ota/disk1/1991/9109/9109.PDF
  179. https://www.gi.alaska.edu/alaska-science-forum/soil-bacteria-gobble-spilled-diesel-fuel
  180. https://pmc.ncbi.nlm.nih.gov/articles/PMC3042690/
  181. https://microbewiki.kenyon.edu/index.php/Pseudomonas_and_Bioremediation
  182. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiomes_-_Health_and_the_Environment_%28Parks%29/04%253A_Environmental_Microbiomes/4.03%253A_Soil_Microbiomes
  183. https://pmc.ncbi.nlm.nih.gov/articles/PMC7916959/
  184. https://pmc.ncbi.nlm.nih.gov/articles/PMC10748132/
  185. https://pmc.ncbi.nlm.nih.gov/articles/PMC8815364/
  186. https://strathprints.strath.ac.uk/72072/1/Cunningham_etal_ESPI_2020_Potential_risks_of_antibiotic_resistant_bacteria_and_genes.pdf
  187. https://pubs.rsc.org/en/content/articlelanding/2020/em/c9em00606k
  188. https://www.sciencedirect.com/science/article/pii/S016041201832381X
  189. https://pmc.ncbi.nlm.nih.gov/articles/PMC4203937/
  190. https://bioresourcesbioprocessing.springeropen.com/articles/10.1186/s40643-021-00419-w
  191. https://www.sciencedirect.com/science/article/pii/S016777992300286X
  192. https://www.sciencedirect.com/science/article/pii/S0042682215001725
  193. https://pmc.ncbi.nlm.nih.gov/articles/PMC9149153/
  194. https://pmc.ncbi.nlm.nih.gov/articles/PMC11744563/
  195. https://pubmed.ncbi.nlm.nih.gov/35070839/
  196. https://www.thelancet.com/journals/laninf/article/PIIS1473309906704959/abstract
  197. https://www.sciencedirect.com/science/article/pii/S2405457724015420
  198. https://www.health.harvard.edu/blog/stool-transplants-are-now-standard-of-care-for-recurrent-c-difficile-infections-2019050916576
  199. https://www.cghjournal.org/article/S1542-3565%2825%2900646-9/abstract
  200. https://www.gastrojournal.org/article/S0016-5085%2818%2935434-9/fulltext
  201. https://www.jci.org/articles/view/187996
  202. https://www.oaepublish.com/articles/mrr.2025.31
  203. https://pmc.ncbi.nlm.nih.gov/articles/PMC12389134/
  204. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2020.02029/full
  205. https://pmc.ncbi.nlm.nih.gov/articles/PMC11494892/
  206. https://pmc.ncbi.nlm.nih.gov/articles/PMC4260394/
  207. https://pmc.ncbi.nlm.nih.gov/articles/PMC3735932/
  208. https://pmc.ncbi.nlm.nih.gov/articles/PMC4095778/
  209. https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.17124
  210. https://pmc.ncbi.nlm.nih.gov/articles/PMC5600545/
  211. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2018.03323/full
  212. https://pmc.ncbi.nlm.nih.gov/articles/PMC8044987/
  213. https://www.science.org/content/article/why-farm-kids-breathe-better
  214. https://pmc.ncbi.nlm.nih.gov/articles/PMC9632986/
  215. https://wwwnc.cdc.gov/eid/article/17/3/10-1881_article
  216. https://pmc.ncbi.nlm.nih.gov/articles/PMC3775492/
  217. https://pubmed.ncbi.nlm.nih.gov/3055197/
  218. https://pmc.ncbi.nlm.nih.gov/articles/PMC10196187/
  219. https://archive.cdc.gov/www_cdc_gov/flu/pandemic-resources/1918-commemoration/1918-pandemic-history.htm
  220. https://www.pnas.org/doi/full/10.1073/pnas.93.25.14304
  221. https://pmc.ncbi.nlm.nih.gov/articles/PMC5778373/
  222. https://pmc.ncbi.nlm.nih.gov/articles/PMC4888801/
  223. https://pmc.ncbi.nlm.nih.gov/articles/PMC6604941/
  224. https://pmc.ncbi.nlm.nih.gov/articles/PMC11362173/
  225. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  226. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2901867-1/fulltext
  227. https://publications.aap.org/pediatrics/article/154/4/e2024068467/199441/Use-of-Antibiotics-in-Animal-Agriculture
  228. https://pmc.ncbi.nlm.nih.gov/articles/PMC6017557/
  229. https://pmc.ncbi.nlm.nih.gov/articles/PMC10675245/
  230. https://pmc.ncbi.nlm.nih.gov/articles/PMC9912134/
  231. https://news.feinberg.northwestern.edu/2022/08/01/antibiotic-stewardship-reduces-unnecessary-prescriptions/
  232. https://jintensivecare.biomedcentral.com/articles/10.1186/s40560-024-00759-7
  233. https://pmc.ncbi.nlm.nih.gov/articles/PMC10146840/
  234. https://www.mdpi.com/2036-7481/14/2/41
  235. https://www.who.int/europe/news-room/fact-sheets/item/bacteriophages-and-their-use-in-combating-antimicrobial-resistance
  236. https://www.mun.ca/biology/scarr/4270_Pasteur_experiment.html
  237. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28Boundless%29/10%253A_Epidemiology/10.01%253A_Principles_of_Epidemiology/10.1D%253A__Kochs_Postulates
  238. https://pmc.ncbi.nlm.nih.gov/articles/PMC8544537/
  239. https://pmc.ncbi.nlm.nih.gov/articles/PMC4980761/
  240. https://www.nature.com/articles/ni1105-1063
  241. https://sciencebasedmedicine.org/your-terrain-your-fault-germ-theory-denial-2025/
  242. https://theconversation.com/germ-theory-denialism-is-alive-and-well-and-taking-the-nuance-out-of-scientific-debate-163408
  243. https://www.popsci.com/health/germ-theory-terrain-theory/
  244. https://www.nature.com/articles/s41564-023-01350-w
  245. https://pmc.ncbi.nlm.nih.gov/articles/PMC10059777/
  246. https://pubmed.ncbi.nlm.nih.gov/37524974/
  247. https://www.science.org/doi/10.1126/scitranslmed.adg2773
  248. https://www.nature.com/articles/s41598-024-57981-4
  249. https://today.ucsd.edu/story/new-findings-may-fix-the-replicability-crisis-in-microbiome-research
  250. https://www.cdc.gov/labs/pdf/SF__19_308133-A_BMBL6_00-BOOK-WEB-final-3.pdf
  251. https://www.domesticpreparedness.com/articles/biosafety-laboratory-issues-and-failures
  252. https://www.chathamhouse.org/laboratory-accidents-and-biocontainment-breaches/issues-need-be-addressed
  253. https://pmc.ncbi.nlm.nih.gov/articles/PMC3899166/
  254. https://www.cidrap.umn.edu/dual-use-research/feds-lift-gain-function-research-pause-offer-guidance
  255. https://pmc.ncbi.nlm.nih.gov/articles/PMC4542197/
  256. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011184
  257. https://thebulletin.org/2014/03/threatened-pandemics-and-laboratory-escapes-self-fulfilling-prophecies/
  258. https://www.ncbi.nlm.nih.gov/books/NBK285579/
  259. https://thebulletin.org/2022/06/gain-of-function-research-cant-deliver-pandemic-predictions-are-there-alternatives/
  260. https://aspr.hhs.gov/S3/Documents/USG-Policy-for-Oversight-of-DURC-and-PEPP-May2024-508.pdf
Add your contribution
Related Hubs
User Avatar
No comments yet.